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Abstract 
Chlamydia is confirmed to modulate host cell death pathways to complete its own 
developmental cycle. A balance between pro- and anti- apoptotic influences by Chlamydia 
has been postulated.  
In this study, the effect of Chlamydia trachomatis on activation of host cell death pathways 
was investigated. C. trachomatis infection induced caspase-3-independent cell death, 
without the stimulation of apoptotic factors like cytochrome c and apoptotic induction 
factor (AIF). On the other hand, after treatment with staurosporine, the activated caspase-3 
and the subsequent apoptotic nuclear fragments displayed in uninfected cells were 
inhibited by chlamydial infection. 
Poly (ADP-ribose) polymerase-1 (PARP-1) is known to play an important role on 
regulating apoptosis and necrosis. During necrosis, it will be over-activated and degraded 
differently from that observed during apoptosis, which exhibited the signature of 89 kDa 
and 24 kDa fragments. After Chlamydia infection, however, PARP-1 was cleaved to 
necrotic-like multi-fragment independent of caspase-3 activation. Strikingly, this cleavage 
was accompanied by a highly decreased enzymatic activity. PARP-1 silencing by siRNA 
in the host cells resulted in cell death similar to that induced by Chlamydia infection, but 
has no effect on chlamydial replicaction.  
Chlamydial but not host cell protein synthesis contributed to this PARP-1 cleavage. Cell 
free degradation assay confirmed that this proteolytic activity only existed in cytosolic 
extractions of infected cells. The purified proteolytic protein fraction after column 
chromatography exhibited a 29 kDa fragment by Coomassie staining. 2D gel 
electrophoresis combined with mass spectrometry proved that this 29 kDa fragment 
corresponds to the NH2-terminal portion of chlamydial proteolytic activity factor (CPAF).  
The high mobility group box-1 (HMGB-1) protein, which is known to be released to the 
extracellular matrix to induce inflammation during necrotic cell death, was also degraded 
by CPAF in the late stage of the chlamydial infectious cycle. This gives the suggestion that 
Chlamydia may evade the host immune system by degrading this inflammatory factor.  
Under the stressful conditions like exposure to IFN-γ, C. trachomatis underwent a special 
form so called “persistence”, which is characterized by enlarged pleomorphic RBs and 
reduced inclusion size, with minimal cultivability and low infectivity. The persistent 
Abstract  2 
 
Chlamydia also exhibited the ability of apoptosis inhibition which ensures the long-term 
persistence in host cells.  
During persistent chlamydial infection, the nuclear proteins PARP-1 and HMGB-1 were 
not degraded, whereas cell free degradation assays with the cytosolic extraction from 
persistently infected cells showed the activity to cleave both proteins, suggesting the CPAF 
translocation to the host nucleus was inhibited during persistence. The pro-apoptotic BH-3 
proteins, degraded by CPAF during active infection, were only slightly degraded during 
persistence. RT-PCR gave the evidence that the expression of CPAF was highly decreased 
during persistent infection. 
Our results gave the convincible evidence that the Chlamydia-secreted protease CPAF, as a 
ubiquitous protease in Chlamydia-infected cells, plays an important role in the regulation 
of host cell death pathways and fulfilling the requirements for chlamydial developmental 
cycle. During active infection this protease degrades many host factors, on the one hand, 
cleavage of nuclear proteins could induce the host cell instability and subsequent cell death, 
on the other hand, the degradation of pro-apoptotic BH-3 protein protect the infected cells 
against apoptotic stimuli. For the long-term persistence in host cells, Chlamydia highly 
decreases the expression of CPAF, which only existed in the cytosol but is not translocated 
to the nucleus. The nuclear proteins kept intact which may make sure the stability of the 
host cells, whereas slight degradation of pro-apoptotic BH-3 protein still support the 
persistent infection resistance to apoptosis.  
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Zusammenfassung 
Chlamydien sind obligat intrazelluläre Bakterien, die die Zelltod-Signalwege ihrer 
Wirtszellen modulieren, um ihren eigenen Eintwicklungszyklus vollenden zu können. Es 
wurde ein Gleichgewicht zwischen zelltodinduzierenden und –inhibierenden Einflüssen 
von Chlamydien postuliert. 
In dieser Studie wurde der Effekt von Chlamydia trachomatis auf die Aktivierung der 
Zelltod-Signalwege der Wirtszelle untersucht. Die Infektion von HeLa-Zellen mit  
C. trachomatis induzierte einen Caspase-3-unabhängigen Zelltod ohne Stimulierung 
verschiedener apoptotischer Faktoren, wie Cytochrom c und Apoptose-Induktions-Faktor 
(AIF). Auf der anderen Seite inhibierte die chlamydiale Infektion die durch Staurosporin 
verursachte Caspase-3-Aktivierung und die anschließende Bildung apoptotischer nukleärer 
Fragmente.  
Poly (ADP-ribose) Polymerase-1 (PARP-1) spielt eine wichtige Rolle bei der Regulation 
von Apoptose und Nekrose. Während eines nekrotischen Zelltodes ist sie überaktiviert und 
zeigt nachfolgend ein anderes Degradierungsmuster im Vergleich zur Apoptose, welche 
durch die Spaltung von PARP-1 in 89 und 24 kDa-Fragmente gekennzeichnet ist. Nach 
Infektion mit Chlamydien hingegen wurde PARP-1 in mehrere Fragmente gespalten und 
zeigte ein Caspase-3-unabhängiges Muster. Auffallend war, dass diese Spaltung mit einer 
starken Reduktion der enzymatischen Aktivität einherging. Die Inhibition der PARP-1-
Synthese in HeLa-Zellen mit Hilfe von siRNA induzierte einen Zelltod. Diese Ergebnisse 
weisen auf eine Rolle der PARP-1-Degradation bei der Induktion eines Zelltodes durch 
Chlamydien hin. 
Die Spaltung von PARP-1 ist abhängig von der chlamydialen Proteinsynthese, jedoch nicht 
von der Wirtszellproteinsynthese. Proteolytische Assays im zellfreien System bestätigten, 
dass diese Aktivität nur in cytosolischen Extrakten infizierter Zellen existierte. Durch 
Säulenchromatographie aufgereinigte proteolytische Fraktionen von cytosolischen 
Extrakten zeigten nach Coomassie-Färbung ein 29 kDa-Fragment. Die Analyse mittels 2D-
Gelelektrophorese und Massenspektrometrie bewiesen, dass dieses 29 kDa-Fragment dem 
NH2-terminalen Teil des chlamydial proteolytic activity factor (CPAF) entspricht.  
Das high mobility group box-1 (HMGB-1) Protein, welches während eines nekrotischen 
Zelltods in die extrazelluläre Matrix abgegeben wird und als proinflammatorischer Faktor 
wirkt, wurde während der späten Phase des chlamydialen Infektionszyklus ebenfalls durch 
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CPAF degradiert. Durch die HMGB-1-Degradation könnten Chlamydien der 
Entzündungsreaktion und Abwehrmechanismen des Immunsystems entgehen.  
Unter Stressbedingungen, z. B. der Stimulation von infizierten Zellen durch IFN- γ, 
können Chlamydien intrazellulär persistierende Formen entwickeln. Diese sind durch 
vergrößerte, pleomorphe Retikularkörperchen charakterisiert, welche sich kaum noch 
replizieren und sich nicht in infektiöse Formen umwandeln. Diese Chlamydienformen 
zeigten ebenfalls die Fähigkeit zur Inhibition der Apoptose, welche offensichtlich die 
Langzeit-Persistenz in den Wirtszellen gewährleistet. 
Während der persistenten chlamydialen Infektion wurden die nukleären Proteine PARP-1 
und HMGB-1 nicht degradiert. Zellfreie proteolytische Assays zeigten hingegen, dass der 
cytosolische Extrakt persistent infizierter Zellen beide Proteine spalten konnte. Dies deutet 
darauf hin, dass die Translokation von CPAF in den Zellkern der Wirtszelle während der 
Persistenz unterdrückt wird. Die proapoptotischen BH3-Proteine, welche während der 
replikativen Infektion durch CPAF abgebaut wurden, waren während der Persistenz nur 
geringfügig degradiert. Mittels RT-PCR konnte bewiesen werden, dass die Expression von 
CPAF während der Persistenz stark reduziert war. 
Die hier dargestellten Ergebnisse zeigen, dass die durch Chlamydien sezernierte Protease 
CPAF eine wichtige Rolle bei der Regulation von Zelltod-Signalwegen der Wirtszelle und 
bei der Komplettierung des chlamydialen Entwicklungszyklus spielt. Während der aktiven 
Infektion spaltet diese Protease eine Reihe von Wirtszellproteinen. Einerseits kann die 
Spaltung von Kernproteinen zur Instabilität der Wirtszelle und zum anschließenden Zelltod 
führen. Andererseits schützt die Degradation von proapoptotischen BH3-Proteinen die 
infizierten Zellen gegenüber Apoptose induzierenden Stimuli. Für die Langzeit-Persistenz 
in ihren Wirtszellen reduzieren Chlamydien die Expression von CPAF, welches unter 
diesen Bedingungen nur in geringen Mengen im Cytosol vorkommt und nicht in den 
Zellkern transloziert wird. Die geringgradige Degradation proapoptotischer BH3-Proteine 
im Cytosol kann die Apoptose-Resistenz der infizierten Zelle aber auch bei einer 
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Abbreviations 
AIF Apoptosis-inducing factors 
BCIP/NBT  5-bromo-4-chloro-3-indolylphosphate toluidine salt-p-nitroblue 
tetrazolium chloride 
BGM Buffalo Green Monkey 
BSA Bovine serum albumin 
CADD Chlamydia protein associated with death domain 
cDNA Complementary deoxyribonucleic acid 
CE Cytosolic extracts 
cHSP60 Chlamydial 60 kDa heat shock protein 
cIAP Inhibitor of apoptosis protein 
CPAF Chlamydial protease-like factor 
DAPI 4'-6-Diamidino-2-phenylindole 
DBD DNA-binding domain 
DISC death inducing signalling complex  
DNA Deoxyribonucleic acid 
EB Elementary body 
ELISA Enzyme-liked immunosorbent assay 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GPIC Guinea pig inclusion conjunctivitis 
HMGB-1 High mobility group box 1-protein 
IAP Inhibitor of apoptosis 
IDO Indoleamine 2, 3-dioxygenase 
IFN-γ Interferon gamma 
IFU Inclusion-forming units 
IgG Immunoglubulin G 
LGV Lymphogranuloma venereum 
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m.o.i. Multiplicity of infection 
MOMP Major outer membrane protein 
mRNA Message ribonucleic acid 
NE Nuclear extracts 
NFκB Nuclear factor kappa B 
PARP-1 Poly (ADP-ribose) polymerase-1 
PBS Phosphate-buffered saline 
PCR Polymerase chain reaction 
PDH Pyruvate dehydrogenase 
p.i. Post infection 
PI Propidium iodide 
PI3K Phosphoinositide-3 kinase 
PKCδ Protein kinase C δ 
PMF Peptide mass fingerprint 
RB Reticulate body 
RLU Relative light units 
RT-PCR Reverse transcriptase polymerase chain reaction 
siRNA Small interfering RNA 
TBS Tris-buffered saline 
TNF α Tumor necrotic factor α 
TNFR Tumor necrosis factor receptor 
TTSS Type III secretion system 
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1 Introduction 
1.1 Chlamydiae 
Chlamydiae are gram-negative obligate intracellular bacteria which target epithelial cells 
of mucosae and replicate within specialized parasitophorous vacuoles. Different species of 
Chlamydia infect a variety of hosts with a wide range of tissue tropisms and varied 
diseases.  
1.1.1 Taxonomy and pathogenesis 
Chlamydiae have been placed in their own order, Chlamydiales, with the family of 
Chlamydiaceae, which was divided in two genera, Chlamydia and Chlamydophila, 
containing altogether nine species (Fig. 1. 1). The genus Chlamydia consists of three 
species, namely C. trachomatis, C. suis and C. muridarum, whereas Cp. psittaci, Cp. 
abortus, Cp. felis, Cp. caviae, Cp. pecorum and Cp. pneumoniae were placed under the 
genus Chlamydophila. Two of these species, C. trachomatis and Cp. pneumoniae, are 














Fig. 1. 1 The classification of Chlamydia (Everett, K. D., 2001) 
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C. trachomatis causes severe infections of the epithelial tissue of eyes and urogenital tract. 
It is divided into three groups of serovars. Serovar A to C is the leading cause of 
preventable blindness in developing countries. Serovar D to K is responsible for the 
majority of sexually transmitted infections; ascending infection by these serovars of the 
female upper genital tract leads to ectopic pregnancy and tubal infertility (Carlin, J. M., 
1995). These infections are also associated with reactive arthritis, which develops in 1 to 
3% of patients after genital chlamydial infection (Wollenhaupt, J., 1990).  Serovar L1 to L3 
shares the unique ability to pass through epithelia, after which they disseminate, invade, 
and destroy lymphatic tissue and cause Lymphogranuloma Venereum (LGV) (Mabey, D., 
2002).  
Cp. pneumoniae is a respiratory pathogen that causes acute and chronic respiratory 
diseases. It is estimated to cause an average of 10% of community-acquired pneumonia 
cases and 5% of bronchitis and sinusitis cases (Kuo, C. C., 1995). Unresolved respiratory 
Cp. pneumoniae infection may contribute to the pathogenesis of chronic inflammatory lung 
diseases (Hahn, D. L., 1991; Blasi, F., 1993). In addition, it also acts as a possible risk 
factor for the development of atherosclerosis (Belland, R. J., 2004) or promoting the 
destabilization of atherosclerosis plaque (Rödel, J., 2004). 
1.1.2 Developmental cycle 
All chlamydial species share a common biphasic developmental cycle (Fig. 1. 2), which 
involves two distinct morphological and functional forms: the smaller (≈ 0.3 µm) 
extracellular, metabolically inactive infectious particles called elementary bodies (EBs) 
and the larger (0.8~1.0 µm) intracellular metabolically active particles termed reticulate 
bodies (RBs) (Abelrahman, Y. M., 2005).  
The EB has a pear shape and possesses a rigid outer membrane with the DNA packed by 
histone-like proteins. The rigidity of EBs is based on cross-linking of three cysteine-rich 
proteins. The most important of these is the major outer membrane protein (MOMP), 
which represents up to 60% of the weight of the outer membrane. The RB possesses a 
fragile membrane lacking the extensive disulfide bonds with tendency to form pleomorphic 
outer envelope blebs. 
Intracellular growth of chlamydia is initiated by the invasion of non-phagocytic epithelial 
cells by infectious, metabolically inactive EBs. The internalized EBs replicate within a 
membrane-bound vacuole termed “inclusion” and differentiate into RBs. This includes the 
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DNA replication and reduction of the disulfide bridges of the outer membrane. RBs 
multiply by binary fission. After 8 to 12 rounds of multiplication, RBs begin to convert 
into EBs, including packing of the DNA and synthesis of late outer membrane proteins that 
are disulfide bridged. At 48 to 72 h post infection (p.i.), depending primarily on the 
infecting species, EBs progeny are eventually released through host cell lysis or extrusion 















Fig. 1. 2 Developmental cycle of Chlamydia. (Beatty, W. L., 1994) 
1.1.3 Chlamydia persistence 
In response to stress conditions, chlamydiae can switch to a special persistent form, which 
is metabolically and morphologically altered and difficult to be eliminated by host cells 
(Hogan, R. J., 2004). Persistent chlamydia has been described as an atypical “aberrant” 
morphology, i.e., enlarged pleomorphic RBs and reduced inclusion size with minimal 
cultivability and low infectivity resulting in a long-term relationship with the infected host 
cell (Beatty, W. L., 1994) (Fig. 1. 2). The persistent chlamydial infection is thought to 
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correlate with many chronic infections, including pelvic inflammatory disease, scarring 
trachoma and reactive arthritis (Hogan, R. J., 2004).  
In vivo, the host response against Chlamydia mostly depends on the inflammatory cytokine 
gamma interferon (IFN-γ). IFN-γ suppresses Chlamydia mainly through the induction of 
tryptophan degrading enzyme indoleamine 2, 3-dioxygenase (IDO). IDO is responsible for 
tryptophan catabolism, thus decreasing the intracellular concentration of tryptophan 
available for chlamydia (Beatty, W. L., 1993). Chlamydia deprived of tryptophan fail to 
complete secondary differentiation into infectious EBs, resulting in the loss of infectivity 
and cell-to-cell transmission and undergoing to the persistent form.  
However, different chlamydial species exhibit differential sensitivities to the effect of  
IFN-γ. For example, the genital serovars (D to K as well as L1 to L3) but not ocular 
serovars (A to C and Ba) of the C. trachomatis displayed the ability to resist on IFN-γ 
exposure. The differences in susceptibility of various chlamydial strains to IFN-γ have 
been explained by the differences in their ability to acquire exogenous tryptophan or to 
synthesize their own tryptophan (Morrison, R. P., 2000; Caldwell, H. D., 2003). 
Despite the evident importance of tryptophan catabolism, other mechanisms such as the 
inducible nitric oxide synthase effector pathway, iron deprivation and antibiotic treatment 
could also induce abnormal Chlamydia RBs. (Igietseme, J. U., 1998).  
1.1.4 Chlamydial effector proteins 
Once internalized, chlamydiae stay inside the inclusion throughout the intracellular stage, 
which lasts for 2 to 4 days depending on the chlamydial species. Like other gram-negative 
pathogens, chlamydiae translocate ‘effector’ proteins into their host cytosol to modulate 
cellular functions. Now it is confirmed that all Chlamydiae code for the core components 
of a type III secretion system (TTSS), a protein transport system used by gram-negative 
bacteria to translocate proteins into the cytoplasm of the host cell, suggesting Chlamydia 
may deliver effector proteins to the inclusion membrane and into the host cell cytoplasm 
by type III secretion (Peter, J., 2007; Clifton, D. R., 2004; Stephens, R. S., 1998; Hsia, R-
c., 1997). So far, evidence for the secretion of chlamydial effector proteins by type III 
secretion has been limited to proteins associated with the inclusion membrane, such as 
CopN (Fields, K. A., 2000) and members of the family of inclusion membrane proteins 
(Inc) (Subtil, C. Parsot, 2001). 
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It should be noted that chlamydial effector proteins also access the cytoplasm of infected 
cells via TTS-independent mechanisms. For example, chlamydial protease-like activity 
factor (CPAF) contains a domain characteristic of bacterial Tail-specific proteases (Tsp) 
(Shaw, A. C., 2002) and is secreted to the inclusion lumen before translocation into the 
cytoplasm of the infected cells (Heuer, D., 2003). 
Throughout the infectious cycle Chlamydia modulate many cellular functions, which 
require the activity of chlamydial effector proteins, including subversion of the 
cytoskeleton to facilitate intracellular redistribution of newly internalized EBs, inhibition 
of apoptosis to ensure intracellular survival during the developmental cycle, induction of 
cell death to release chlamydial progeny upon completion of the cycle, and evasion of host 
immune system recognition (Carabeo, R. A., 2002). For example, the Incs are probably 
central regulators of bacterial-host interactions. IncA mediates homotypic fusion of 
inclusions potentially by forming a SNARE-like fusogenic intermediate between adjacent 
inclusions (Hackstadt, T., 1999; Delevoye, C., 2004). IncG sequesters the host protein 14-
3-3β and its pro-apoptotic binding partner phosphor-BAD (Verbeke, P., 2006).  
Another prominent function of these effector proteins is to interfere with the host cell death 
programs which are central to innate immune responses. During middle stage of infection, 
the CPAF degrades pro-apoptotic BH-3 proteins to shut down the infected cell’s ability to 
undergo apoptosis in response to intrinsic and extrinsic stimuli. Finally, Chlamydia 
infection significantly impacts the cell cycle of infected cells by cleavage of the mitotic 
cyclin B1and delays in cytokinesis (Balsara, Z. R., 2006; Greene, W., 2003). These later 
functions lead to genomic instability, which in conjunction with the strong anti-apoptotic 
effect of chlamydial infection may explain how Chlamydia modulate host cell death 
programs to fulfil its unique intracellular parasite lifestyle.  
1.2 Cell death  
In general, cellular homeostasis is maintained by a balance between proliferation and cell 
death. Two major types of cell death are described as apoptosis and necrosis. 
1.2.1 Apoptosis 
Apoptosis is a well-conserved process that multicellular organisms use for control of 
development and homeostasis as well as the removal of unwanted cells recognized by the 
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immune system. Common morphological and biochemical features of apoptosis include 
nuclear chromatin condensation, cytoplasmic shrinking, dilated endoplasmic reticulum, 
blebbing of plasma membrane, phosphatidylserine asymmetry, internucleosomal DNA 
fragmentation, reduction of mitochondrial transmembrane potential, intracellular 
acidification, etc (Vaux, D. L., 1994; Wyllie, A. H., 1997; Golstein, P., 1991). 
Apoptosis can be induced through both extrinsic and intrinsic pathways (Hengartner, M. 
O., 2000; Krammer, P. H., 2000; Green, D. R., 1998; Salvesen, G. S., 2002). The intrinsic 
pathway involves the activation of several pro-caspases followed by the mitochondria 
released apoptotic factors. The extrinsic pathway involves the activation of the death 
receptors, FAS and tumor necrosis factor receptors (TNFR). In most cases, both pathways 
require the release of mitochondrial cytochrome c, which in turn binds to Apaf-1 and 
caspase 9 to form an apoptosome, the caspase-activating signaling complex (Ekert, P. G., 
2005). Subsequently, caspases get activated and cleave cystein-containing proteins like 
lamins, poly (ADP-ribose) polymerase 1 (PARP-1), histones, nucleolin, and fodrin, thus 
leading to cell death (Fig. 1. 3). Now, the cleavage of PARP-1 in fragments of 89 kDa and 
24 kDa by activated caspase-3 and 7 has become a useful hallmark of apoptosis.  
The release of cytochrome c is regulated by Bcl-2 family proteins. This family consists of 
three groups of proteins: the pro-apoptotic subfamily (Bax, Bak and Bok), which directly 
alters the integrity of the mitochondrial membrane and causes cytochrome c release; anti-
apoptotic proteins Bcl-2 and Bcl-xl, which inhibit cytochrome c release; and the BH-3 only 
proteins that exhibit pro-apoptotic activity by inhibition of Bcl-2 or Bcl-xl. c-FLIP is a 
critical negative regulator of the extrinsic cell death pathway. It functions as a competitive 
inhibitor of pro-caspase 8. Upon death receptor stimulation, c-FLIP can be efficiently 
recruited to the death inducing signalling complex (DISC) and inhibit pro-caspase 8 
activation at the DISC (Zhang, N., 2005).  
Two types of cells have been identified with regards to the requirement for a mitochondrial 
amplification loop during apoptosis. In type II cells (HeLa, Jurkat, and human CEM T-cell 
line), apoptosis inducers can activate caspase-3 only through a mitochondrion-dependent 
step. In type I cells (human B lymphoblast cell line SKW6.4, H9, BJAB), caspase-8 
recruitment and activation by cell surface receptors can lead directly to caspase-3 
activation without help from mitochondria (Barnhart, B. C., 2003).  
 























Fig. 1. 3 Apoptotic pathway (Zhang, N., 2005) 
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1.2.2 Necrosis 
In contrast to apoptosis, necrosis has generally been considered as an unregulated form of 
cell death which is associated with acute injury to cells. It results in plasma membrane 
disintegration and leakage of cellular contents to stimulate inflammation (Cohen, G. M., 
1997; Fiers, W., 1999). 
Necrosis has long been described as a consequence of extreme physico-chemical stress, 
such as heat, osmotic shock, mechanical stress, freeze-thawing and high concentration of 
hydrogen peroxide. Under these conditions, cell death occurs quickly due to the direct 
effect of the stressor on the cell, and therefore this cell death process has been described as 
accidental and uncontrolled. However, recently many different cellular stimuli (TNF on 
certain cell lines, dsRNA, ATP depletion, ischemia) have been shown to induce a necrotic 
process that follows defined steps and signalling events reminiscent of a true cell death 
program (Vanden Berghe, T., 2007). This induced necrotic cell death results from 
extensive crosstalk between several biochemical and molecular events at different cellular 
levels, and it is similarly controlled like apoptosis.  
It is important to distinguish necrosis from other forms of cell death, particularly because it 
is often associated with unwarranted loss of cells in human pathologies. It can also lead to 
local inflammation due to release intracellular factors from dead cells; the so-called 
damage associated molecular patterns that alert the innate immune system. Now the 
different cleavages of PARP-1 have become the method to distinguish apoptosis and 
necrosis. During necrosis, the PARP-1 is cleaved to the multi-fragment form (72, 55 and 
42 kDa) by the lysosomal proteases (Gobeil, S., 2001). This necrotic PARP-1 cleavage 
could also induce the release of the high mobility group box 1 protein (HMGB-1), which 
further stimulates monocytes to secrete a subset of pro-inflammatory cytokines and act as 
an important inflammatory factor (Ditsworth, D., 2007; Müller, S., 2001).  
However, there is no other clear biochemical definition of necrotic cell death and 
consequently no specific biochemical markers that unambiguously discriminate necrosis 
from apoptosis. Another problem is that even the interpretation of dying cell morphology 
may be complex, because in the absence of phagocytosis apoptotic cells proceed to a stage 
called secondary necrosis, which shares many features with primary necrosis.  
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1.3 Chlamydia regulates host cells death pathway 
As an intracellular pathogen, Chlamydia replicates strictly in a vacuole in the host cytosol. 
Thus, it is essential to maintain the integrity of host cells during its developmental cycle 
not only for supplying the nutrients but also for protecting the intracellular organisms from 
host phagocytosis and antigen-specific immune effectors. However, at the later stage, the 
host cells rupture benefits on the release of elementary bodies to start a new infectious 
cycle. Therefore, modulation of the host cell death could be a relevant component of the 
chlamydial developmental cycle.  
1.3.1 Chlamydia inhibits apoptosis 
The anti-apoptotic activity of Chlamydia has consistently been demonstrated by its ability 
to inhibit chemically and spontaneously induced apoptosis during mid to late stages in the 
developmental cycle. The paper in 1998 first described that, C. trachomatis-infected cells 
are resistant to numerous experimental apoptotic stimuli, exhibiting inhibition of caspase 
activation and blockage of cytochrome c release from mitochondria (Fan, T., 1998). Later, 
several studies have shown that epithelial cells or monocytes that are infected with C. 
trachomatis or Cp. pneumoniae are protected against cell death stimuli (D. Dean, 2001; 
Fischer, S. F., 2001, 2004; Rajalingam, K., 2001; Greene, W., 2004).  
An explanation for these observations could be the proteolytic cleavage of a wide range of 
pro-apoptotic BH-3 only proteins (Fischer, S. F., 2004). It is now known that Chlamydia 
are capable to degrade the pro-apoptotic proteins Puma, Bad, Noxa and tBid (Ying, S., 
2005), a family of proteins that share this Bcl-2 homology domain. The secreted 
chlamydial protease CPAF was confirmed to be responsible for this degradation, thus 
ensuring a complete shut down of the infected cell’s ability to undergo apoptosis in 
response to intrinsic and extrinsic stimuli.  
Besides the BH-3 only proteins degradation, chlamydial infection also results in activation 
of the phosphoinositide-3 kinase (PI3K) pathway. During infection with C. trachomatis, 
activation of PI3K leads to Akt activation and in turn to phosphorylation of a pro-apoptotic 
protein, Bad. C. trachomatis prevents phosphorylated Bad from binding to mitochondria 
by sequestering their binding partners, 14-3-3β proteins, via a chlamydial inclusion 
membrane protein IncG (Verbeke, P., 2006).  
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Additionally, Chlamydia appears to be capable of accumulating diacylglycerol in the 
inclusion, which recruits and sequesters pro-apoptotic effector protein kinase C δ (PKCδ). 
When PKCδ is activated, it is cleaved to release a catalytically active fragment that 
translocates to the mitochondria where it promotes the release of cytochrome c and 
subsequently activates of the apoptotic pathway (Tse, S. M., 2005). Thus, chlamydial 
recruiting PKCδ could protect the mitochondria against the death signal.  
Anti-apoptotic gene regulation through nuclear factor NF-κB-mediated gene activation is 
an anti-apoptotic mechanism used by other pathogens, but conflicting results exist for 
Chlamydia. Cp. pneumoniae infection of a human monocytic cell line induced expression 
of nuclear factor kappa B (NF-κB) and the inhibitor of apoptosis 2 (IAP2). Inhibition of 
NF-κB by proteosome inhibitor MG132 resulted in inhibition of IAP2 and induction of 
apoptosis (Wahl, C., 2003). However, other studies is failed to demonstrate the function of 
NF-κB activation in C. trachomatis inhibition of apoptosis. Neither chemical inhibition nor 
gene deletion of NF-κB had any effect on anti-apoptotic activity of C. trachomatis (Xiao, 















Fig. 1. 4 The inhibition of apoptosis by Chlamydia (Miyairi, I., 2006) 
 
Introduction  17 
 
1.3.2 Chlamydia induces cell death  
Cytotoxicity associated with chlamydial infection has been reported for many years. 
Chlamydia infection was thought to be lytic for the host cells. Productive cell culture 
infections ultimately result in host cell lysis (Abdelrahman, Y. M., 2005). Cell death seems 
to occur in uninfected neighboring cells or in infected cells at later stages of infection. 
Though the cells displayed some morphological characteristics of apoptotic death, there is 
no classical caspase activation (Ojcius, D. M., 1998; Schoier, J., 2001; Dumrese, C., 2005). 
Another publication suggested an additional possibility, namely, that Cp. pneumoniae 
induces a form of cell death which displays some apoptotic features, but is more consistent 
with necrosis. The term “aponecrosis” has been proposed to characterize this special death 
form induced by Chlamydia infection (Dumrese, C., 2005). These findings suggest that an 
ongoing death stimulus by chlamydial infection exists to induce the host cell death in the 
late stage of infection.  
It is indicated that the pro-apoptotic protein Bax is activated during Chlamydia infection 
with the guinea pig inclusion conjunctivitis (GPIC) serovar of Cp. psittaci (J. L. Perfettini, 
2002), giving an explanation for the Chlamydia induced caspase-independent cell death. 
One Chlamydia protein associated with death domain (CADD)— an iron-containing redox 
enzyme unique to chlamydial species, can induce cell death when ectopically expressed in 
mammalian cells by interacting with death domains of tumor necrosis factor (TNF) family 
of receptors (Stenner-Liewen, F., 2002). Host cytokines such as tumor necrotic factor α 
(TNF-α) (Jendro, M. C., 2004) have been implicated as sources of pro-apoptotic stimuli. 
Cp. pneumoniae infection is also known to modulate oxLDL-induced endothelial cell death, 
decreasing apoptosis and promoting necrosis (Nazzal, D., 2006). In addition, Chlamydia-
induced necrosis might be associated with a heterogeneous family of clostridia cytotoxin 
homologues that are coded by the genomes of C. trachomatis and Cp. psittaci (Belland, R. 
J., 2001). 
1.3.3 Chlamydial persistence regulate cell death 
During persistent infection, the antigenic profile of Chlamydia differs from that of acute 
infection. Beatty et al. (1993, 1994) proposed that during chlamydial persistence, the 
reduced levels of MOMP, an immunoprotective antigen, could enable chlamydiae to avoid 
the development of protective immunity. On the other hand, steady of chlamydial 60 kDa 
heat shock protein (cHSP60) levels would promote immunopathology of persistent 
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chlamydia. Hypersensitivity reactions are known to be elicited by cHSP60 (Morrison, R. 
P., 1989, 1991; Patton, D. L., 1994), which is confirmed to induce apoptosis (Equils, O., 
2006); suggesting that an apoptotic block may favour a chlamydial form that expresses 
inflammation-inducing proteins. 
It has been reported that cells infected with C. trachomatis in the presence of IFN-γ resist 
apoptosis due to external ligands, via inhibition of caspase activation (Dean, D., 2001). 
During persistent chlamydial infection, cytochorome c remained sequestered in the 
mitochondrial fraction after apoptotic induction (Deborah, D., 2001). The mechanism of 
protection in persistently infected cells seems to be the same as that observed in the 
absence of IFN-γ.  
Furthermore, anti-apoptotic activity is prolonged during chlamydial persistence, which 
strengthens the hypothesis that active chlamydial metabolism maintains host cell integrity 
and contributes to intracellular survival (Dean, D., 2001; Perfettini, J. L., 2002). However, 
the precise mechanisms and factors that Chlamydia uses to modulate host cell death 
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1.4 Aim of this work 
In summary, to fulfill the long-term intracellular survive, Chlamydia is confirmed to inhibit 
the death stimuli for the host cells during the developmental cycle and spontaneously 
induce some kind of cell death to release the reproduced EBs. When this pathogen is under 
the conditional stress like exposure to IFN-γ, it goes to a persistent form, which also 
exhibits abilities to protect the host cells against death stimuli and prevent the elimination 
by the host immune system. However, until now, the precise factors and mechanisms of 
how Chlamydia regulates host cell death pathways to fulfill its specific developmental 
cycle and the differences on this regulation between active and persistent infection are still 
unclear. It is unclear how the balance between cell death induction versus apoptosis 
inhibition is regulated in Chlamydia infected cells and which factors are involved.  
The objective of my work can be described as follows: 
1. To characterize the host cell death induced by C. trachomatis and to illuminate the 
mechanisms which Chlamydia used to regulate host death pathways.  
2. To detect the factors like nuclear proteins PARP-1 and HMGB-1, which are 
involved in keeping host cell integrity and homeostasis, and to investigate the 
function of these factors in Chlamydia induced host cell death. 
3. To compare the differences of cell death regulation between active and persistent 
infection, and explain how Chlamydia can modify host cell death pathways under 
different conditions. 
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2 Material and methods 
2.1 Material  
Strain Company 
C. trachomatis serovar D strain IC Cal 8 Institute of Ophthalmology, London, United 
Kingdom 
 
Cell lines and culture medium Company 
BGM cell American Type Culture Collection, ATCC; 
Manassas, VA  
Fetal calf serum PromoCell, Heidelberg, Germany 
HeLa cell ATCC; Manassas, VA 
Minimal Essential Medium (OptiMEM, 
Gibco) 
Invitrogen, Karlsruhe, Germany 
Panserin medium Panbiotech 
SF-3 medium Cytogen, Lohmar, Germany 
 
Material  Company 
25-cm2 flasks CellStar; Greiner Bio-One GmbH, 
Frickenhausen, Germany 
6-well plates Nunclon TM, Roskilde, Denmark 
8-well LabTec chamber Nunclon TM, Roskilde, Denmark 
96-well plates Nunclon TM, Roskilde, Denmark 
AKTA purifier 10 instruments Pharmacia Biotech Inc 
IPG dry strips GE Healthcare Life Sciences 
Mono Q ion exchange column Amersham Pharmacia Biotech Inc. 
Semidry transblot system Bio-Rad, Munich, Germany 
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Buffer and solution Compound 
Bjerrum and Schafer-Nielsen Transfer 
buffer 
48mM Tris, 39 mM glycine, 1.3 mM SDS, 
20% methanol (pH ~9) 
Blocking buffer 4% bovine serum albumin,  0.05% Tween, 
TBS 
Buffer B for Cell free degradation 0.5 mM NaCl, 1% Triton X-100 in 20 mM 
Tris (pH 8.0) 
Buffer A for chromatography 0.01 M Tris, pH 7.2 
Buffer B for chromatography 0.01 M Tris, 1 M NaCl, pH 7.2) 
Equilibration buffer 6 M urea, 30% (w/v) glycerol and 2% (w/v) 
SDS in 0.05 M Tris-HCl buffer, pH 8.8.  
Gel fixing solution 40% methanol, 7% glacial acetic acid 
Gel staining solution 10% methanol, 0.1% CBB G-250, 1.6% o-
phosphoric acid, and 10% (w/v) ammonium 
sulfate 
HiPerfect transfection reagent Qiagen, Hilden, Germany 
IPG blocking buffer 7 M urea, 2 M thiourea, 2% CHAPS, 
0.002% bromophenol blue, 0.5% IPG buffer, 
1.2% De-Streak Reagent 
Laemmli sample buffer Bio-Rad, Munich, Germany 
Neutralised solution 0.1 M Tris-base titrated to pH 6.5 with o-
phosphoric acid 
Saccharose phosphate buffer PBS with 0.2 M saccharose and 2% FCS 
 
Chemical Company 
Aprotinin Sigma, US 
Bovine serum albumin (BSA) Sigma, US 
Chloroamphenicol Biocat, Heidelberg, Germany 
Cycloheximide Biocat, Heidelberg, Germany 
DAPI Invitrogen 
DMSO Sigma, US 
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Gel strengthener Molecular Probes, Leiden, The Netherlands 
Hoechst 34580 Invitrogen, Karlsruhe, Germany 
Lactacystin Enzo Life Sciences, Lörrach, Germany 
Leupeptin Serva, Heidelberg, Germany 
Methanol Mallinckrodt Baker, Deventer, Holland 
Paraformaldehyde Sigma, US 
Phenylmethylsulfony fluoride (PMSF) Serva, Heidelberg, Germany 
Propidium iodide (PI) Biotium, purchased from Biotrend, Cologne, 
Germany 
Protein standard Mark 12 Invitrogen, Karlsruhe, Germany 
SDS-PAGE Standards Broad Range Bio-Rad, Munich, Germany 
Sodium dodecyl sulfate (SDS) Sigma, US 
Staurosporine Roche Applied Science, Mannheim, 
Germany 
Sulforhodamine 101-annexin V Biotium, Hayward, CA 
SYBR Green I (Molecular Probes; MoBiTec; Göttingen, 
Germany 
TBS-tween Sigma, US 
Trypsin Biochrom AG 
 
Kits Company 
Annexin V-FLUOS staining kit Roche Applied Science, Mannheim, 
Germany 
Caspase-Glo® 3/7 Assay Promega, Mannheim, Germany 
DEVD-NucViewTM caspase-3 Biotium, Hayward, CA 
HMGB-1 enzyme-linked immunosorbent 
assay 
Shino-test, Kanagawa, Japan 
HP validated small interfering RNA 
(siRNA)  
Invitrogen, Carlsbad, CA 
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Promega reverse transcription system Promega, Mannheim, Germany 
Rnase-Free Dnase Set Qiagen, Hilden, Germany 
RNeasy Mini Kit Qiagen, Hilden, Germany 





toluidine salt-p-nitroblue tetrazolium 
chloride  (BCIP/NBT substrate) 
Sigma Fast, Sigma-Aldrich 
Alkaline phosphatase-conjugated goat anti-
rabbit/mouse IgG 
Dianova, Hamburg, Germany 
Mouse monoclonal antibody to chlamydial 
CPAF 
Kindly provided by Dr. V. Forsbach-Birk, 
Institute of Medical Microbiology, 
University of Ulm, Germany 
Mouse monoclonal antibody to Chlamydia 
trachomatis heat shock protein 60 
(cHSP60)  
Acris, Hiddenhausen, Germany 
Mouse monoclonal antibody to Chlamydia 
trachomatis (MOMP) 
Acris 
Rabbit polyclonal antibody to human Bad Cell-Signalling Tech 
Rabbit polyclonal antibody to human Bim 
(BOD) 
Sigma, US 
Rabbit polyclonal antibodies to GAPDH Santa Cruz Biotechnology 
Rabbit polyclonal antibody to human 
HMGB-1 
Abcam, Cambridge, UK 
Rabbit polyclonal antibody to IDO Santa Cruz Biotechnology 
Rabbit polyclonal antibody to human 
Puma/bbc3, N-terminal 
Sigma, US 
Taxas-conjugated goat anti-rabbit/ mouse 
IgG (H+L) 
Santa Cruz Biotechnology 
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Primer Sequence 






HP validated small interfering RNA 
(siRNA) targeting PARP-1 (SI02662989) 
Qiagen, Hilden, Germany 
nonsilencing All Stars Negative Control 
siRNA 




Machine  Company 
Branson Sonifier W-250 Heinemann, Germany 
Confocal laser scanning microscope (TCS 
SP5) 
Leica, Heidelberg, Germany 
Confocal laser scanning microscope (Zeiss) Zeiss, Jena, Germany 
Ettan DALT System GE Healthcare Life Sciences 
FACSCalibur flow cytometer BD Biosciences, Heidelberg, Germany 
Fluorescence microscope Axioskop, Zeiss, Jena, Germany 
IPGphorTM GE Healthcare Life Sciences 
Semidry transblot system Bio-Rad, Munich, Germany 
Protean II xi multicell system Bio-Rad, Munich, Germany 
TRIO-Thermoblock Biometra, Göttingen, Germany 
Ultraflex I device Bruker Daltonics, Bremen, Germany 
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Software Company 
Cell QuestPro BD Biosciences, Heidelberg, Germany 
Labscan software 5 GE Healthcare Life Sciences 
MASCOT interface (MASCOT 2.1.0) Matrix Science, London, UK 
ProFound Genomic Solutions, USA 
2.2 Methods  
2.2.1 Cell culture and Chlamydia organisms 
HeLa cells (ATCC CCL-2) were grown in minimal essential medium with 10% fetal calf 
serum (FCS).  
C. trachomatis serovar D strain IC Cal 8 (obtained from the Institute of Ophthalmology, 
London, United Kingdom) was propagated in buffalo green monkey (BGM) cells. C. 
trachomatis D were inoculated onto cell monolayers in 25-cm2 flasks and centrifuged at 
2,000 × g for 45 min at 37oC. The inoculum was removed and replaced with serum-free 
SF-3 medium. Infected cells were collected in phosphate-buffered saline (PBS) with 0.2 M 
sucrose and 2% FCS 48 h after infection and lysed by sonication. The chlamydial 
suspension was centrifuged at 800 × g to remove cellular debris. Supernatants were stored 
at -70oC. Infectivity titers of chlamydial stocks were quantified by titrating the number of 
inclusion-forming units (IFU) per milliliter in BGM cells. Mycoplasma contaminations in 
cell cultures were excluded by PCR targeting the 16S rRNA gene of Mycoplasma, 
Acholeplasma, and Ureaplasma species (Hotzel, H., 1998).  
2.2.2 Infection and induction of persistence 
For infection experiments, HeLa cells were grown in 35-mm-diameter culture wells (six-
well plates) or 11-mm-diameter culture tube containing a glass coverslip (shell-vials) to c. 
70% confluence. The cells were inoculated with C. trachomatis at a multiplicity of 
infection (m.o.i.) of 5. For mock-infected cultures diluted harvests of uninfected BGM 
cells were added. After centrifugation at 4,000 × g at 37oC for 45 min, the inoculum was 
decanted, and the cells were further incubated with OptiMEM containing 10% FCS. 
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To induce the persistence, HeLa cells were preincubated 48 h before infection with 
different concentration of IFN-γ. After infection, the medium were changed and new IFN-γ 
was added.  
For inhibition experiments, the prokaryotic protein synthesis inhibitor chloroamphenicol 
(60 µg/ mL) or the eukaryotic protein synthesis inhibitor cycloheximide (10 µg/ mL) were 
added to the cultures directly after infection.  
2.2.3 Immunofluorescence staining of Chlamydia trachomatis 
Infected HeLa cell monolayers grown on coverslips were fixed with methanol at 48 h post 
infection. Samples were incubated with a FITC-conjugated antibody to the C. trachomatis 
major outer membrane protein (MOMP).  
The number of inclusions per shell vial was calculated from determination of inclusions in 
20 randomly selected × 400 microscopic fields under a fluorescence microscope. 
2.2.4 Detection of cell death by PI/Hoechst staining and flow cytometry 
HeLa cells grown and infected in 8-well LabTec chambers were washed with PBS at 48 h 
after infection and fixed with 4% paraformaldehyde for 30 min. Then the cells were 
incubated with 10 µM of Hoechst 34580 to stain DNA and propidium iodide (PI) to stain 
dead cells. Images were taken with a confocal laser scanning microscope.  
For the identification of cell death by flow cytometry, the Annexin V-FLUOS Staining Kit 
was used to detect Phosphatidylserine exposure and PI incorporation. Culture supernatants 
were collected and mixed with trypsinized cells. After centrifugation at 3000 × g for 4 min, 
samples were washed in PBS and resuspended in the supplied buffer containing annexin 
V-FLUOS labeling reagent and PI. After 20 min incubation at room temperature, labeled 
cells were analyzed with a FACSCalibur flow cytometer and Cell QuestPro Software. 
Then thousand cells were scored for each sample.  
2.2.5 Apoptosis induction and assay for nuclear morphology   
To induce apoptosis, cells with or without chlamydial infection were treated with 1 μM 
staurosporine for 4 h. For nuclear morphology assays cells grown on coverslips were used 
for infection. After apoptosis induction cells were washed twice with PBS, fixed with 
methanol for 5 min at room temperature, and stained with 1 µM DAPI at 37 oC for 30 min. 
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After being washed three times with PBS, nuclear fragmentation was examined under a 
fluorescence microscope. Nuclei in 10 randomly selected visual fields were counted and 
the percentage of apoptotic cells was calculated.   
2.2.6 Localization of active caspase-3, cytochrome c, and AIF  
For the detection of active caspase-3 HeLa cells were cultured in 8-well LabTek chambers. 
Mock-infected and infected cells with or without staurosporine treatment were incubated 
with a caspase-3-specific chromogenic substrate (NucView 488 Caspase-3 Assay Kit), 
FITC conjugated-annexin V, and Hoechst 34580. The procedures were performed as 
described by the manufacture. Fluorescence-labeled samples were examined under a 
confocal laser scanning microscope.  
For cytochrome c and AIF staining HeLa cells grown and infected on coverslips (shell vial 
cultures) were washed in PBS and fixed with 4% paraformaldehyde for 15 min at room 
temperature. The slides were incubated with 1:100 dilutions of rabbit polyclonal antibodies 
to cytochrome c or AIF for 1 h at 37 oC. As secondary antibody Texas Red-conjugated 
goat anti-rabbit IgG (H+L) was used at a dilution of 1:50. Washings between antibody 
addition were performed with PBS three times. Finally, the cells were stained with Hoechst 
34580. Images were taken with a confocal laser scanning microscope.  
2.2.7 Detection of the caspase-3 /7 activity 
Cells were grown and infected on 96-well microtiter plates. The caspase-3/7 activity was 
measured using a Caspase-Glo ® 3/7 Assay (Promega). The assay provides a luminogenic 
caspase-3/7 substrate, which contains the tetrapeptide sequence DEVD, in a reagent 
optimized for caspase activity, luciferase activity and cell lysis. Following caspase-3/7 
cleavage, a substrate for luciferase is released, resulting in the luciferase reaction and the 
production of light. Luminescence was measured by a plate-reading luminometer, and the 
activity of caspase-3/7 is presented as the number of relative light units (RLU). 
2.2.8 Immunoblotting 
Cells were lysed in radioimmunoassay buffer for 30 min on ice. Cell lysates were 
centrifuged in a microcentrifuge at 5,000 g at 4 oC for 15 min, and the supernatants were 
mixed with an equal volume of Laemmli sample buffer. The samples were electrophoresed 
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on 10-12% polyacrylamide-SDS gels. Transfer of fractionated proteins to nitrocellulose 
membranes was carried out with a semidry transblot system (Bio-Rad, Munich, Germany) 
using Bjerrum and Schafer-Nielsen transfer buffer. Blots were blocked with 4% bovine 
serum albumin (BSA) in Tris-buffered saline (TBS) containing 0.05% Tween 20 for 4h. 
Blots were incubated with 1:1,000 dilutions of rabbit polyclonal antibodies to PARP-1 
(VIC 5), HMGB-1 (ab18256), Bim (BOD), Puma/bb3 N-terminal, Bad, GAPDH (FL-335), 
IDO (H-110) and mouse polyclonal antibodies to cHSP60, MOMP at 4oC overnight. 
Alkaline phosphatase-conjugated goat anti-rabbit/mouse IgG was used as secondary 
antibody at a dilution of 1:1,000. Blots were incubated with the secondary antibody for 2 h 
at room temperature. Washings between antibodies additions were performed with TBS-
Tween three times for 10 min. The bands were visualized with 5-bromo-4-chloro-3-
indolylphosphate toluidine salt-p-nitroblue tetrazolium chloride (BCIP/NBT substrate). 
Molecular weights of proteins and their fragments were calculated from a plot of log 
molecular weight vs. distance migrated for protein standards in the gels. 
2.2.9 Cell free degradation assay 
Cells grown and infected on six-well plates were trypsinized and harvested by 
centrifugation at 1.800 × g for 10 min at 4°C. After being washed with ice-cold PBS, the 
cell pellet was resuspended in 5 volumes of ice-cold buffer A. After incubation on ice for 
15 min, the cells were disrupted by agitation 15 times. Nuclear pellets were collected by 
centrifugation at 1,000 × g for 10 min at 4°C and further extracted in buffer B. The 
supernatants were centrifuged at 20,000 × g for 15 min to prepare cytosolic extracts. 
Cytosolic extracts prepared from mock-infected and Chlamydia-infected cells were used as 
the source of enzyme and incubated with nuclear extracts from mock-infected HeLa cells 
as substrate containing PARP-1 and HMGB-1. After 2 h incubation at 37°C, the mixtures 
were analyzed by SDS-PAGE and immunoblotting.  
2.2.10 Column Chromatography 
To separate proteolytic proteins that were induced in infected HeLa cells, cytosolic extracts 
were applied to a Mono Q ion exchange column (GE Healthcare Life Sciences, Freiburg, 
Germany). An AKTA purifier 10 instruments (GE Healthcare Life Sciences) was used to 
run the column. Anion exchange was performed with buffer B (0.01 M Tris, 1 M NaCl, pH 
7.2) and the column was eluted with buffer A (0.01 M Tris, pH 7.2). Proteolytic acitivities 
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of the fractions against PARP-1 and HMGB-1 cleavage were measured using cell-free 
degradation assays as described above. Proteolytic fractions were analyzed for the presence 
of bands by SDS-PAGE and Coomassie Brilliant Blue staining was performed to analyze 
proteolytic fractions for the presence of protein bands that were absent in non-PARP-1-
degrading fractions. Immunoblots of proteolytic fractions were stained with a mouse 
monoclonal antibody to CPAF (kindly provided by Dr. V. Forsbach-Birk, Institute of 
Medical Microbiology, University of Ulm, Germany). Alkaline phosphatase-conjugated 
goat anti-mouse IgG was used as secondary antibody at a dilution of 1: 1,000.  
2.2.11 2-D Gel Electrophoreses  
Chromatography fractions which showed proteolytic activity (23 to 27) were collected and 
used for two-dimensional gel electrophoresis. The 24-cm IPG strip covering a non-linear 
pH range of 3-11 was rehydrated overnight in buffer containg 7 M urea, 2 M thiourea, 2% 
CHAPS, 0.002% bromophenol blue, 0.5% IPG buffer, 1.2% De-Streak Reagent. Isoelectric 
focusing was carried out using the IPGphor II with a manifold ceramic tray at 20 oC with a 
current of 50 μA/ strip. The amount of 300 μg protein was loaded and isoelectric focusing 
was applied by the following protocol: 3 h at 300 V, 3 h at 600 V, 4 h at 1,000 V, 3 h at 
8,000 V, and 24,000 Vh at 8,000 V. Prior to the second dimension the strip was 
equilibrated for 15 min in 10 ml equilibration buffer containing 1% DTT and subsequently 
for 15 min in 10 ml equilibration buffer containing 2.5% iodoacetamide. The separation in 
the second dimension was performed on the Ettan DALT System with 12.5% SDS-
polyacrylamide gels containing rhinohide as a gel strengthener (30 min 30 W, 4 h 100 W 
for six Ettan Dalt gels). Protein standard Mark 12 was used for compare the molecular 
weight of proteins. The gel was fixed for 2 h in a fixing solution, washed twice with 
ultrafiltrated water for 20 min and stained overnight in a gel staining solution. The gel was 
further neutralised (0.1 M Tris-base titrated to pH 6.5 with σ-phosphoric acid) for 5 min 
and washed in 25% methanol for 1 h. The stained gel was scanned and calibrated with 
Labscan software 5.  
2.2.12 Mass Spectrometry 
Protein spots were excised manually. Tryptic digest of proteins and MALDI-TOF were 
carried out in Hans Knöll Institute, Jena, Germany. The protein spots were digested 
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according to the protocol of Bruker. MALDI-TOF spectra were generated with an 
Ultraflex I device (Bruker Daltonics, Bremen, Germany).  
Peptide mass fingerprint (PMF) was submitted for identification using MASCOT interface 
(MASCOT 2.1.0) or ProFound. The masses were compared to peptide masses generated by 
a theoretical tryptic cleavage of proteins present in databases (http://au.expasy.org) for 
protein identification. 
2.2.13 Enzyme-linked immunosorbent assay (ELISA) for HMGB-1 and 
PARP-1 
For enzyme immunoassays, supernatants of infected and mock-infected cultures were 
centrifugated at 14,000 × g for 5 min and stored at -80 oC until assayed. Levels of 
extracelllular HMGB-1 were measured by HMGB-1 enzyme-linked immunosorbent assay 
according to the manufacturer’s protocol.  
PARP activity in cell lysates was assayed using the universal colorimetric PARP assay kit 
according to the manufacturer’s instructions. The test principle is based on the 
incorporation of biotinylated Poly (ADP-ribose) onto histone proteins. Poly (ADP-
ribosylation) of histone proteins was detected using streptavidin-HRP. Briefly, cell lysates 
from uninfected and C. trachomatis infected cells containing 20 µg of protein were loaded 
into a 96-well plate coated with histones and biotinylated poly ADP-ribose, allowed to 
incubate for 1 h, treated with strep-HRP, and read at 450 nm in a spectrophotometer. 
2.2.14 PARP-1 RNA interference and transfection 
HP validated small interfering RNA (siRNA) targeting PARP-1 (SI02662989) and 
nonsilencing All Stars Negative Control siRNA were purchased from Qiagen (Hilden, 
Germany). HeLa cells were transfected with 5 nM siRNA using HiPerfect transfection 
reagent (Qiagen) according to the manufacturer’s protocol. At 16 h post transfection, the 
medium was changed to remove the transfection reagent. At 48 h post transfection, cells 
were further infected by C. trachomatis at m.o.i. 5, PARP-1 expression level and cell death 
induction and were assayed as described above. 
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2.2.15 Lactacystin treatment and Chlamydia replication assay 
Lactacystin was dissolved in DMSO at a concentration of 1,1 mg/ml. To inhibit CPAF 
activity HeLa cells grown in 6-well plates were treated with 11 µg lactacystin after C. 
trachomatis infection (final concentration 10 µM). Control wells of mock-infected and 
infected cells included DMSO at an equivalent dilution. After 48 h cell lysates were 
prepared in radioimmunoassay buffer for SDS-PAGE. In comparison infected cells 
cultured in medium alone were collected in radioimmunoassay buffer and then treated with 
11 µg of lactacystin for 45 min on ice. Chlamydial inclusions in HeLa cells treated with or 
without lactacystin were quantified after immunofluorescence staining with FITC-
conjugated antibody to the C. trachomatis MOMP.  
To assess the production of new infectious elementary bodies during the intracellular 
cycle, infected cells were scraped into 0.5 ml of saccharose phosphate buffer at 48 h after 
infection and lysed by sonication (ten pulses at 110 W; Branson Sonifier W-250). To titrate 
the inclusion-forming units (IFU) of the chlamydial suspensions BGM cells were infected 
with serial dilutions by centrifugation and incubated in serum-free Panserin medium for 48 
h. Chlamydial inclusions were counted after immunofluorescence staining to determine the 
IFU per shell vial. The chlamydial yield was calculated from the ratio of IFU to the 
number of inclusions.   
2.2.16 RNA extraction and reverse transcription (RT)-PCR analysis 
Total RNA was prepared from cell monolayers using the RNeasy Mini Kit according to the 
manufacturer’s instructions. To avoid the DNA contamination for certain RNA 
applications that are sensitive to very small amounts of DNA, the residual DNA were be 
removed by optional on column DNase digestion using the RNase-Free DNase Set. To 
remove the First-strand cDNA was reverse transcribed from 1 µg of RNA in a total 
reaction volume of 20 µL with 15 U of  avian myeloblastosis virus reverse transcriptase 
and 0.5 µg of oligo(dT)15 primer, using the Promega reverse transcription system as 
instructed by the manufacturer.  
Each 25 µL of PCR mixture contained 0.5 µL of cDNA (corresponding to 25 ng of RNA), 
10 mM Tris-HCl (pH 8.3), 50 mM KCl, 0.2 mM each dNTP, 1.5 mM MgCl2, 0.4 µM sense 
and antisense  primers, and 1.25 U of Taq DNA polymerase (Promega). cDNA was 
amplified for pyruvate dehydrogenase (PDH) as reference. Thirty cycles of amplification 
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were carried out in a TRIO-Thermoblock. Reactions consisted of an initial incubation at 95 
oC for 7 min and then cycling at 95 oC for 30 s, 55 oC (annealing temperature) for 30 s, and 
72 oC for 1 min, with a final incubation at 72 oC. Negative controls were performed by 
omitting RNA from cDNA synthesis and PCR amplification. Products were 
electrophoresed on 1 % agarose gels containing SYBR Green I and visualized on a UV 
transilluminator.  
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3 Results 
3.1 Regulation of host cell death by C. trachomatis active infection 
3.1.1 C. trachomatis active infected cells induce necrotic-like cell death 
As an intracellular pathogen, Chlamydia is known to induce severe host cell damage and 
subsequent inflammation. HeLa cells were infected with C. trachomatis serovar D at a 
multiplicity of infection (m.o.i.) of 5 and double-stained with Hoechst 34580 and propidium 
iodide (PI). Hoechst 34580 (excitation/ emission maxima ≈ 350/ 461 nm), is a type of blue-
fluorescence dye which can bound to DNA. PI, a red-fluorescence dye (excitation/ emission 
maxima ≈ 535/ 617 nm), is only staining the cells with membrane damage. As shown in Fig. 
3. 1, a numerous PI-positive cells were present in the cultures at 48 h post infection, 














Mock infected Infected 
  25 µm 
Fig. 3. 1 Induction of cell death in response to C. trachomatis infection.  
HeLa cells were infected at an m.o.i. of 5 and stained with Hoechst 34580 (blue) and PI (pink) at 48 h post 
infection. Mock infected cells were used as control. 
 
For flow cytometry double-labeling of the cells with annexin V and PI was used. Annexin V 
binds phosphatidylserine which is typically exposed on the outer leaflet of apoptotic cell 
membranes. PI was used for the discrimination of necrotic cells from the annexin V-
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positively stained cell clusters. As the result shown in Fig. 3. 2 A, after C. trachomatis D 
infection both PI and annexin V double-positive cells was observed. The cell death induced 
by Chlamydia is significantly increased at a time dependent manner. At the earlier stage of 
infection (10 h p.i.), the cell death was only slightly induced compared to mock infected 
cells; however, at 24 h and 48 h p.i., about 28.8% and 34.7% cells underwent cell death, 
respectively (Fig. 3. 2 B).  
3.1.2 Resistance against apoptotic stimuli by C. trachomatis infected cells 
Many studies already confirmed that Chlamydia showed the ability to protect infected cells 
against apoptotic stimuli. To evaluate whether in our cell culture model C. trachomatis 
infected cells also exhibited an extensive resistance to apoptosis despite the cell death 
induction, both mock infected and infected HeLa cells were treated with 1 µM staurosporine, 
a protein kinase inhibitor, for 4 h. Morphology of cell nuclei was assessed by staining with 
nuclear dye DAPI (4'-6-Diamidino-2-phenylindole). DAPI is known to form fluorescent 
complexes with natural double-stranded DNA. The results in Fig. 3. 3A confirmed that under 
the apoptotic stimuli, uninfected cells clearly showed nuclear condensation and 
fragmentation, which are hallmarks for apoptosis, whereas no apoptotic nuclei were 
displayed in chlamydial inclusion-containing cells, proving the inhibition of apoptosis by 
chlamydial infection.  
Inhibition of staurosporine-induced apoptosis was quantified by counting apoptotic nuclei 
under the microscope after staining with DAPI. At 24 h and 48 h post infection, the cells 
with apoptotic nuclei following staurosporine treatment were reduced to 5.6% and 0.9% 
respectively, compared to 24.1% in mock-infected cultures. But earlier stage of infection (10 
h p.i.) has no clear effect on the apoptotic inhibition (Fig. 3. 3 B). These findings confirmed 
that the model used in this study is not contradictory to those used in studies that clearly 




















Fig. 3. 2 Cell death during infection of HeLa cells with C. trachomatis, measured by flow cytometry with 
annexin V- PI double-labeled cells.  
A. Dot blots of mock-infected and infected cells analyzed by flow cytometry with annexin V/PI double 
labeling.  
B. Time course of cell death induction by chlamydial infection. Results are given as the percentage of PI-
positive cells (with standard deviations) as measured by flow cytometry.  
*, P ≤ 0.03, compared with values for infected cells at 0 and 10 h (n = 4);  
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Fig. 3. 3 Protection of infected cells against staurosporine-mediated apoptosis 
A. HeLa cells were infected at an m.o.i. of 5 and apoptosis was induced by 1µM staurosporine for 4 h. The 
morphology of nuclear was stained with DAPI. Mock infected cells used as control. (Apoptotic nuclei are 
indicated with arrows and chlamydial inclusions are indicated with stars.) 
B. The percentage of cells with apoptotic nuclei was calculated from the determination of nuclear apoptosis 
after DAPI staining and counting cells in ten random microscopic fields at a magnification of 400. 
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3.1.3 Caspase-3 is not activated during C. trachomatis infection 
During apoptosis, the effector caspase-3 is cleaved from a non-activated 32 kDa form to an 
activated 19 kDa form, which cleaves and stimulates many death substrate factors like 
PARP-1, lamins and Fordrin. To detect if the C. trachomatis-induced cell death depends on 
caspase-3 activity, both mock infected and infected cells were stained with Hoechst 34580 
(blue), annexin V (green), and a caspase-3 specific chromogenic substrate (red). Staining for 
the cleaved epitope that is generated during proteolytic activation of caspase-3 in apoptosis 
did not yield any evidence of caspase-3 activation in both cells, suggesting the C. 
trachomatis induced cell death is independent of caspase-3 activity. 
As a control, apoptosis was induced using 1 µM staurosporine for 4 h. Under apoptotic 
stimuli, mock-infected cells clearly showed nuclear condensation and fragments associated 
with positive staining for active caspase-3 and annexin V. In contrast, cells containing a 
chlamydial inclusion showed no nuclear fragmentation and inhibition of activated caspase-3 
(Fig. 3. 4 A).  
The activity of caspase-3 was quantified by using a luminescence assay. The results in Fig. 
3. 4 B showed that after the treatment of staurosporine, the activity of caspase-3 in HeLa 
cells extraction was 1,8 fold increased, whereas the chlamydial infected cells exhibited no 
caspase-3 activation compared to mock infected cells.  
All these results confirmed that C. trachomatis induced cell death is independent of caspase-
3 activity and chlamydial infection could protect host cells against apoptosis by blocking the 























 3. 4 Lack
. Cells with and without infection at an m.o.i. of 5 were incubated in medium alone or treated with 
porine for 4 h. The cell samples were stained with Hoechst 34580, annexin V, and an antibody specific 
for activated caspase-3. Cells were viewed under a confocal laser scanning microscope.  
B. The quantitative activity of caspase-3 based on luminescence assay. The activity of caspase-3 was presented 
s the number of relative light units (RLU).  
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3.1.4 Mitochondrial factors are not activated during C. trachomatis infection 
It is demonstrated that cell death during infection does not involve the activation of caspase-
. To confirm that host cell death induced by C. trachomatis is not mediated by the 
itochondrial pathway, HeLa cells were stained with antibodies against cytochrome c and 
poptosis-inducing factors (AIF), which are released from mitochondria to act as pro-
poptotic factors.  
Fi
HeLa cells were stained with Hoechst 34580 and antibodies against cytochrome c or AIF at 48 h after infection. 
Note that neither cytochrome c nor AIF (red) are released from mitochondria in cells containing a chlamydial 
inclusion. 
 
As shown in Fig. 3. 5, the cytochrome c in normal HeLa cells is mainly located in the 
mitochondria; after 48 h C. trachomatis infection, each infected cell was followed by a very 
big chlamydial inclusion, however, cytochrome c still displayed a clear location in 





g. 3. 5 C. trachomatis-induced cell death is obviously independent of the activation of apoptotic pathways.  
 15 µm 
Mock infected   Infected 
15 µm 
Cytochrome c 
    15 µm       15 
Mock infected Infected 
       AIF 
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e nucleus and directly induce nuclear fragments by caspase-independent 
. 
PARP-1 is cleaved to a multi-form during C. trachomatis infection 
s a nuclear DNA-binding enzyme involved in base excision repair, PARP-1 represents an 
a 
ladder form with prominent bands at 71, 55, and 42 kDa, corresponding to necrotic cleavage 
 
 
Fig n of P-1 f owing ctio  C. mat
Whole c tracts wer t diffe t time points after infecti  and analyzed by immunoblotting. 
Mock infected cells and apoptosis cells induced by staurosporine were used as control. 
 
mitochondrion to th
apoptosis, was also remained in mitochondria after infection. This demonstrated that C
trachomatis infection failed to activate mitochondria-dependent death pathway of host cell. 
3.1.5 
A
important factor involved in the regulation of apoptosis and necrosis (Gobeil, S et al. 2001). 
It is confirmed to be cleaved into different forms when the cells are treated with different 
stimuli. During classical apoptosis induced by staurosporine, the full-length PARP-1 protein 
of 113 kDa is cleaved into two fragments of 24 and 89 kDa by activated caspase-3. While 
the cells undergo necrosis, it will be overactivated and cleaved to a multi-pattern (Kaufmann, 
S. H., 1993; Lazebnik, Y. A., 1994; Gobeil, S., 2001).  
Interestingly, following C. trachomatis infection, PARP-1 was found to be cleaved into 
(Fig. 3. 6). The degradation of PARP-1 started at approximately 16 h post infection, a time
point at which chlamydiae are in the active phase. 
 
C. trachomatis - - 8 h 12 h 16 h 20 h 24 h 32 h 












. 3. 6 Degradatio PAR oll  infe n with tracho is 
ell ex e prepared a ren on
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3.1.6 PARP-1 cleavage depends of chlamydial but not host protein synthesis 
o determine whether prokaryotic or host cell protein synthesis is required for PARP-1 
leavage, infected cells were treated with chloramphenicol and cycloheximide, respectively. 
hloramphenicol is known to suppress only prokaryotic but not eukaryotic protein synthesis 
at the concentration used in the experiment, while cycloheximide is an inhibitor of 
prokaryotic cells. As shown in Fig. 3. 7, 
ggesting that the new synthesis 
g that a chlamydial 
roteolytic factor causes PARP-1 fragmentation. 
x, cycloheximide. 10 µg/ mL. 
 
Cell-f adation says we  used urthe aracterize the PARP-1-degrading 
roteolytic activity induced by C. trachomatis. Nuclear extracts (NE) from mock-infected 
HeLa cells were used as the source of PARP-1 protein; c extracts (CE) from 
hlamydia-infected cells were used as the source of proteolytic factors, and CE from mock-
fected cells were used as control.  
s shown in Fig. 3. 8, when NE of HeLa cells were incubated with CE from mock-infected 
ells the PARP-1 protein keep intact. In contrast, the incubatio  CE from infected cells 
resulted in a total cleavage of PARP-1. These observations demonstrated that the protease 




eukaryotic translation, but has no effect on 
cycloheximide did not prevent the degradation of PARP-1, su
of host cell proteases is not required. In contrast, full-length PARP-1 but no cleaved 
fragments were detected in cells treated with chloramphenicol, indicatin
p
C. trachomatis - + + + 






Fig. 3. 7 Effects of cycloheximide and chloramphenicol treatment on the fragmentation of PARP-1 in infected 













factors which cleaved the nuclear protein PARP-1 existed only in chlamydia
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It should be noted that the band sizes observed in the cell-free degradation assays using CE 
somewhat differ from those observed in NE harvested from infected cells but this may be 
explained by further degradation into smaller fragments resulting from the experimental 
conditions. 
 
NE Mock  Infection  Mock Mock 
 
 
Fig. 3. 8 Presen e of t eolytic activit g 1  nuclear fractions of 
lamydia-infected but not mock-infected cells.  
solic and nuclear fractions were prepared from cell samples collected at 48 h after and analyzed 
y immunoblotting. Cytosolic fractions from mock-infected and infected cells were tested in a cell-free 
eavage assay using nuclear fractions from mock-infected cells as the PARP-1-containing substrate. 
E, nuclear extract; CE, cytosolic extract  
3.1.7 Induction of PARP-1 cleavage by chlamydial proteasome-like activity 
factor (CPAF) 
To identify the Chlamydia-specific proteolytic factor responsible for PARP-1 cleavage, a 
sed to separate this proteolytic factor. A Mono Q 
column was used to purify fractions from cytosolic extracts of infected HeLa cells. 50 
ubstrate. 
olytic activity (Fig. 3. 9 A), which correlated with the 
appearance of protein bands at 29 kDa in SDS-PAGE gels (Fig. 3. 9 B).  
Fractions 24 to 26 were collected and separated by 2D gel electrophoresis to further separate 
this protein. Protein spots were cut out from a Coomassie blue-stained gel and subjected to 
CE  Mock  Infection Mock Infection 
  




 71 kDa 
 55 kDa 
 42 kDa 







column chromatography approach was u
fractions eluted from Mono Q column were tested for a PARP-1-degrading activity in 
immunoblot assays. The nuclear extracts from uninfected HeLa cells were used as s
Fractions 23 to 28 showed a prote
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analys ith the database, a spot with the estimated coordinates of 29 kDa 
and pI 7 matched to a protease, the NH -terminal portion of the chlamydial protease-like 
 
 24 25 26 27 28 
 
 
ig. 3. 9 Separation of proteolytic fraction from chlamydial infected cells CE by column chromatogr
. Cytosolic lysates of cells infected at an m.o.i. of 5 were fractionated by Mono Q column chromatography. 
Fractions were examined for PARP-1 cleavage in a cell-free assay using nuclear extracts of uninfected cells as 
bstrate. Cleavage of PARP-1 was detected by immunoblotting.  
otein profiles of proteolytic fractions were monitored by Coomassiestaining of SDS-polyacrylamide gels. 
Note that PARP-1-cleaving fractions showed band of 29 kDa that was absent in fractions without proteolytic 
ac
digest by trypsin for sequence identification. Using MALDI-TOF mass spectrometry 
is and comparison w
2
activity factor (CPAF) (Fig. 3. 10 A). Immunoblots of proteolytic fractions that were stained 
with a CPAF antibody confirmed that the bands detected in SDS-PAGE gels represent 
proteins of CPAF (Fig. 3. 10 B). 
A.  






Fraction 21 22 23
113 kDa 
 71 kDa 
 55 kDa 
 42 kDa 
  29 kDa 
 






Results  44 
 
.  
PAF: GTAAEESAALR (162-172) 
        YVPEGVGDLATIAPSIR (210-226) 
B.  
Fraction 21 22 23 24 25 26 27 28 
ig. 3. 10 Identification of CPAF as the proteolytic factor which degrades PARP-1.  
ons were subjected to 2D-PAGE separation. The enlarged panel shows a 
29 kDa-spot which was analyzed by MALDI-TOF and identified as CPAF. 


















    
 
 29 kDa  
 
F
A. Proteolytic Mono Q column fracti
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3.1.8 Cleaved PARP-1 in infected cells loses its polymerase activity 
 response to apoptotic cell death, PARP-1 cleavage by caspase-3 acts as a me  that 
revents apoptotic cells from repairing DNA. It shows a corresponding decrease in PARP-1 
lymerase activity. To detect 
ional 
hibition, HeLa cells were infected with C. trachomatis at m.o.i. 5, nuclear proteins were 
collected from mock-infected and infected HeLa cells at different time points after infection 
measuring the incorporation of biotinylated 
cells with resulted in a significant decrease of PARP-1 enzymatic activity at 
 
Fig. 3. 1
Each co a y a 
colorimetric enzyme activity assay. *, P ≤ 0.01, compared with values for infected cells at 0 and 6 h (n = 3).   
In chanism
p
activity consistent with the known cleavage.  
It could be supposed that the degradation of full-length PARP-1 into multiple fragments by 
Chlamydia infection also results in a loss of (ADP-ribose) po
whether the specific cleavage of PARP-1 by chlamydial infection is related to funct
in
and the activity of PARP-1 was calculated by 
Poly (ADP-ribose) onto histone proteins. As illustrated in Figure 3. 11, the infection of HeLa 
C. trachomatis 
24 and 48 h after infection, corresponding to the degree of PARP-1 cleavage detected in 







































Time after infection (h)
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1 PARP-1 activity in different time course after C. trachomatis infection.  
lumn represents the medial value from three experimetns. Total cell lysates were an
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3.1.9 Silencing of PARP-1 induces host cell death without inhibition of 
chlamydial developmental cycle 
ext experiments should help to clarify whether the loss of PARP-1 acitivity in HeLa cells 
ay promote cell death. HeLa cells were transfected with a specific siRNA to silence PARP-
1 expression. Non-silencing siRNA served as a negative control. As shown by immunoblot 
nM of PARP-1 siRNA was sufficient to inhibit PARP-1 
rotein expression in HeLa cells, whereas PARP-1 was presented normally following control 
-transfected cells also 
y 
u
si PARP-1 Negative control 
N
m
analysis, transfection with 10 
p
siRNA transfection. After C. trachomatis infection, control siRNA
showed PARP-1 degradation (Fig. 3. 12 A). 
As shown by flow cytometry, PARP-1 silencing in uninfected HeLa cells induced nearl
30% of PI-positive cells which was comparable to the percentage of PI-positive cells in 
infected cultures, while negative control siRNA exhibited similar cell death rate like 
ninfected cells (Fig. 3. 12 B). 
To further investigate if PARP-1 cleavage also has effects on the replication of C. 
trachomatis, HeLa cells transfected with either siRNA PARP-1 or negative control were 
infected with C. trachomatis. The chlamydial inclusions were visualised using FITC-
conjugated anti-chlamydial antibody. After 48 h infection, infected cells were sonificated to 
harvest newly produced EBs, which can be used to infect new cells to get the titre of 
chlamydial yield. The graph shown in Fig. 3. 12 C gave the statistics result of 4 different 
experiments, which demonstrated that silencing of PARP-1 has no significant effect on the 
chlamydial developmental cycle compared to the negative control siRNA transfection.  
A.  
si RNA - - 


















 3. 12  cycle. 
. Downregulation of PARP-1 protein in HeLa cells by siRNA transfection. Cells were transfected with PARP-
1-specific and nonsilencing siRNA and incubated for 48 h. PARP-1 was analyzed by immunoblotting. 
easured by flow cytometry with PI labelling. Chlamydia-infected cells served as control. *, 
 ≤ 0.03, compared with values for mock-infected cells incubated in medium alone or transfected with control 
 = 4).  
C. PARP-1 silencing effect on the chlamydial developmental cycle. After si RNA transfection, HeLa cells were 
fected with C. trachomatis D. 48 h post infection, the EBs were collected to infect new BGM cells to measure 
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Fig. Effect of PARP-1 silencing on the host cell death and chlamydial developmental
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3.1.10 CPAF also contributes to HMGB-1 degradation in infected cells 
igh mobility group box 1 protein (HMGB-1) was identified as an important mediator of 
chromatin-
ellular 
extracellular HMGB-1 levels were measured by enzyme-liked immunosorbent assay 
ants of C. trachomatis-infected cells as compared to those of mock-infected 
cultures; although the uninfected cells showed the increase of HMGB-1 level corresponding 
 
Fig. 3. 1
Time  mock-infected and infected cells. HMGB-1 levels in culture 
supernatants were determin





endotoxin lethality. HMGB-1 is a nuclear protein which acts as an architectural 
binding factor that binds DNA and promotes protein assembly on specific DNA targets. 
During necrotic but not apoptotic cell death this factor can be released into the extrac
space to elicit a potent inflammatory response (Scaffidi, P., 2002).  
To detect if HMGB-1 is also released during the Chlamydia-induced host cell death, the 
(ELISA). Interestingly, at 48 h after infection lower amounts of HMGB-1 were measured in 
supernat
















3 Extracellular level of HMGB-1 in C. trachomatis-infected HeLa cell culture.  
 course of HMGB-1 released from
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. 
C. trachomatis - + - + - + 
 6 h 6 h 24 h 24 h 48 h 48 h 
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ig. 3. 14 Degradation of HMGB-1 in C. trachomatis-infected HeLa cells.  
. HMGB-1 levels in infected cells determined by immunoblotting. GAPDH was stain eference band.  
. Degradation of HMGB-1 in a cell-free cleavage assay. Cytosolic and nuclear fractions were prepared from 
mples collected at 48 h after infection. Cytosolic fractions from mock-infected and infected cells were 
n a cleavage assay using nuclear fractions from mock-infected cells as the HMGB1-containing substrate. 
HM ein w termined by immunoblotting. , nuclea tract; CE, cytosolic extract..  
C. Mono Q fractions of cytosolic lysates from infected cells were examined for HMGB-1 cleavage using 
uclear extracts of uninfected cells as substrate. HMGB-1 was determined by immunoblotting. Note that 















25 kDa  
F




GB1 prot as de NE r ex
n
H
Results  50 
 
he intracellular HMGB-1 protein level was further evaluated by Western blot. Interestingly, 
munoblot analysis revealed that at 48 h after chlamydial infection, the full-length 25 kDa 
HMGB-1 protein was highly degraded, instead a faint smaller band of 17 kDa could be 
detected, which may due to a certain proteolytic degradation of HMGB-1 (Fig. 3.14 A).  
Concerning that the degradation of the inflammatory factor HMGB-1 may also be induced 
more, the 
To examine that CPAF also contributes to HMGB-1 degradation, CPAF-enriched Mono Q 
concentration 5 µM to inhibit CPAF activity shortly after C. trachomatis infection. The 
To exclude that PARP-1 and HMGB-1 degradation is artificially caused by CPAF during the 
colle n in lysis buffer. In this case, 
lactacystin had no effect on PARP-1 and HMGB-1 cleavage (Fig. 3. 15).  
T
im
by the chlamydial protease; the cell free degradation assay was performed to. The blot in Fig. 
3. 14 B demonstrated that both cytosolic and nuclear extracts from infected cells contained 
lower amounts of HMGB-1 than those from mock-infected cells. Further
incubation of NE from mock-infected cells with CE from infected cells resulted in a 
complete loss of the HMGB-1 full-length protein.  
column fractions were tested for a proteolytic activity against HMGB-1. As shown in Fig. 
3.14 C, fractions 23 to 26 caused HMGB-1 cleavage whereas fractions 21 and 22 in which 
no CPAF could be detected were inactive (see also Fig. 3. 9). 
3.1.11 The effect of lactacystin, a CPAF inhibitor, on PARP-1/HMGB-1 
cleavage and chlamydial replication 
To further confirm that CPAF functions as the proteolytic factor to degrade PARP-1 and 
HMGB-1, lactacystin, an inhibitor of the 26S proteasome, which has also been identified to 
inhibit the activity of CPAF (Zhong, G., 2001), was added to the cell culture at the final 
immunoblotting shown in Figure 3. 15 also gave the result that both proteins kept intact after 
the inhibition of CPAF activity, which gave evidence that CPAF is necessary and sufficient 
to degrade the host proteins.  
preparation of cell lysates for immunoblotting, infected cells cultured in medium alone were 
cted and treated with lactacystin during incubatio
However, the addition of lactacystin on infected HeLa cells did not significantly affect the 
production of chlamydial elementary bodies during the replication cycle (Fig. 3. 16), 
suggesting that the degradation of nuclear proteins acted only as a mechanism of chlamydial 
interfering with host functions.  
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- 5 µM 5 µM 
 
 
Fig. 3. 15 Lactacystin effect on the cleavage of PARP-1 and HMGB-1.  
Cells were infected with C. trachomatis at an MOI of 5. 11 µg of lactacystin per 35-mm-diameter well were 
added to the culture medium after infection (final concentration 10 µM) or to the cell harvests when lysates for 
SDS-PAGE were prepared. Cells were collected at 48 h after infection and analyzed for PARP-1 and HMGB-1 







Fig. 3. 16 Replication of C. trachomatis in HeLa cells treated with lactacystin.  
Chlamydial yield was calculated from the determination of inclusions and titration of newly produced 
C. trachomatis - + + + 
Lactacystin - 









































elementary bodies. Each column was performed using three different experiments. 
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3.2.1 IFN-γ inhibition of C. trachomatis D infectivity and induction of 
persistence  
ther stud  have demonstrated that IFN- γ suppressed chlamydial growth and the 
roduction infectious EBs progeny (Beatty, W. L., 1993). It is confirmed that Chlamydia 
 differential sensitivities to the growth inhibitory effects of IFN-γ. C. 
trachomati  is partly resistant to IFN-γ because it possesses a functional tryptophan 
nthase a is capable of utilizing indole as a substrate for tryptophan synthesis, thus it 
ould coun ct the tryptophan depletion induced by IFN-γ (Morrison, R. P., 2000).  
o establish the in vitro persistent infection model of C. trachomatis D, HeLa cells were pre-
eated with different concentrations of IFN-γ prior to infection to starve the tryptophan pool 
of the cells. After 48 h pre-treatment, cells were infected with C. trachomatis D at m.o.i. 5 
 of IFN-γ was added 
of infection and the reproduction of the EBs was measured by infecting BGM cells. Fig. 3.17 
illustrates that IFN-γ caused transition of chlamydial to the persistent state. The reproduction 
; 
although it has no significant effect on the inclusion numbers.  
Chlam ibiting abnormal morphology were also observed in IFN-γ induced 
persistently infected cells. Immunofluorescence images in Fig. 3. 18 revealed aberrant forms, 
 













and mock infected cells were used as control. The same concentration
on the culture immediately after infection. The inclusions numbers were calculated after 48 h 
of EBs was drastically reduced after 48 h post infection when 5 ng/ mL IFN-γ was added
ydial bodies exh
i.e. the inclusions appeared to be smaller and RBs were larger than those seen with active, 
IFN-γ untreated C. trachomatis infection. At higher magnification, images of aberrant 
inclusions revealed characteristic inhomogeneities resulting from the enlarged bodies, which 














ig. 3. 17 
ssess t  pre-treated with 
N- γ for 48 h.  Cells were infected with C. trachomatis D at m.o.i. 5 and further IFN-γ was added on the 
lture directly after infection. The inclusions numbers were calculated after 48 h of infection and the 
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ig. 3. 18 Morphology of chlamydial inclusions during active and persistent infection.  
sed to induce persistence. To illustrate inclusion morphology, magnifications of typical chlamydial inclusions 
e shown in the lower right images.  
3.2.2 Differential protein expression during persistent infection 
IFN-γ affects human host cells in vitro by inducing IDO, a nonconstitutive enzyme that 
catalyzes the initial step in the degradation of tryptophan to N-formylkynurenine and 
kynurenine (Taylor, M. W., 1991, Beatty, W. L, 1994). 
To confirm IDO expression induced by IFN- γ, Western blot assays were carried out. After 
48 h pre-treatment with the indicated concentration of IFN-γ, HeLa cells were infected with 
C. trachomatis D (m.o.i. 5). The IFN-γ was further used to induce persistence directly after 
infection, active non-treated infections served as controls. Total protein was isolated at 48 h 
post infection and expression levels of IDO related to persistence were shown in Figure 3. 
19. IDO expression can be detected under the 5 ng/ mL IFN-γ treatment, which gave another 
dia persistence (see 
infection, but the MOMP protein level was highly decreased under the induction of 5 ng/ mL 
IFN-γ at the same time point of 48 h. In contrast, the cHSP60 was expressed at a constant 
F
HeLa cells monolayers infected with C. trachomaits D were fixed with paraformaldehyde and stained with 
Hoechst 34580 (blue) to show the morphology of nucleus (stars) and inclusion (arrows). 5 ng/mL IFN-γ was 
u
ar
evidence that 5 ng/ mL IFN-γ is a necessary dose for inducing Chlamy
Fig. 3. 17).  
In order to confirm the IFN-γ induced persistence, the cHSP60 and MOMP proteins were 
investigated using western blot. Both MOMP and cHSP60 were expressed during active 
      Active infection           Persistent infection 
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ease of MOMP-
cHSP60-ratio and was consistent with the other reports (Betty, W. L., 1993), suggesting 
10 20 
Different concentrations of IFN-γ were used to induce persistence. Mock infected cells and active infected cells 
(m  as c rol. W e cell racts re pr d a 48 h  infection and analyzed by 
imm
3 Chlamydi
ies illustrated that the active Chlamydia infection modulates host cell death 
against apoptotic stimuli and 
Chlamydia, 
ells persistently infected by C. trachomatis D were further induced apoptosis by 1 
M staurosporine for 4 h. To elucidate the effect of IFN-γ, the mock infected cells were 
ith the 
level in persistent infection (Fig. 3. 19). This result displayed the clear decr
persistent state of Chlamydia was established after the IFN-γ treatment.  
IFN-γ (ng/ mL)  0 1 2 5 











Fig. 3. 19 Western blot analyses of specific gene expression which is relative to IFN-γ induced persistence of 
C. trachomatis D. 
.o.i. 5) were used ont hol  ext we epare fter  post
unoblotting. 
3.2. a persistence resists on apoptotic stimuli  
Initial stud
pathways in opposite directions, both protecting infected cells 
inducing caspase-3 independent cell death. 
To detect if the apoptotic inhibition activity is also exhibited in the persistent 
HeLa c
µ
treated w same concentration of IFN-γ as control.  
 





. HeLa cells were pre-treated with 5 ng/ γ for 48 h and follow with C. trachomatis D 
t m.o.i. 5. After 48 h post infection, 1 µM staurosporine was added on the cell culture for 4 h to induce 
apoptosis. The nuclear morphology was stained by Hoechst 34580 (blue) and the chlamydial inclusions were 
d by the FITC-conjugated anti-chlamydial antibody (green). 
. The numbers counting of the apoptotic nuclei in both uninfected and persistently infected cells after the 
























F . 3. 20 Inhibition of apoptosis by persistent Chlamydia infection. 
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s shown in Fig 3. 20 A, after treatment with staurosporine, apoptotic nuclei existed in 
ock-infected cells, displaying nuclear condensation and fragmentation which are hallmarks 
f apoptosis. Although IFN-γ itself induced some apoptosis in chlamydial inclusion-negative 
ells, whereas the cells with persistent Chlamydia could efficiently inhibit the apoptotic 
orphology.  
he counting of the apoptotic nuclei gave the results that after apoptotic stimuli, the mock 
ore apoptotic nuclei, whereas upon the Chlamydia persistent 
infection, only 9% more cells displayed the apoptotic nuclei, suggesting the inhibition of 
apoptosis by the persistent Chlamydia infection (Fig 3. 20 B). 
3.2.4 Nuclear proteins keep intact during C. trachomatis infection  
We already showed that during C. trachomatis active infection, host cell nuclear proteins 
 
ere performed to detect these proteins in persistently infected cells. As 







infected showed 50,41% m
PARP-1 and HMGB-1 are cleaved by chlamydial protease-like activity factor (CPAF). The 
cleavage of nuclear proteins contributes to the chlamydial regulation host cell death 
pathways and prevents the inflammation factor release. 
To further investigate if these factors were also related to chlamydial persistence, Western 
blot analysis w
displayed in Figure 3. 21, the nuclear proteins PARP-1 and HMGB-1 were both intact in 
nucleus during chlamydial persistence compared to the proteolytic cleavage pattern in active 
infection. The protection of these proteins against cleavage also showed an IFN-γ dose 
dependent manner, by treated with 5 ng/ mL IFN-γ, the cleavage of PARP-1 only showed a 
faint band in 42 kDa,
with the persistence inducing ability of IFN-γ, suggesting that the nuclear proteins kept 
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Fig. 3. 21 Degradation of PARP-1 and HMGB-1 following persistent infection of Chlamydia  
fferent concentrations of IFN-γ were added on the chlamydial infected (m.o.i. 5) cell culture. Mock infected 
lls and active infected cells were used as control. Whole cell extracts were prepared after 48 h post infection 
 analyzed by immunoblotting. 
 
3.2.5 Expression level of CPAF correlates with suppression of host proteins 
degradation during persistent infection  
To  d tial gene e ressi  of CPAF in active and persistent infection, 
verse transcription PCR was performed. The PCR showed that the CPAF transcription 
started at 12 h post infection in active infection culture, and got to maximum at 24 h post 
en the chlamydia has its most activity (Fig. 3. 22 A). However, during persistent 
fection, 5 ng/ mL IFN-γ efficiently decreased but not totally inhibited the CPAF 
anscription (Fig. 3. 22 B), suggesting that during the persistent infection, CPAF was still 





























 3. 22 CPAF transcription differences in active vs. persistent infection.  
A. HeLa cells were infected with C. trachomatis (m.o.i. 5). Total RNA was extracted at different time points 
aft NA were rmine T-PCR ysis. M nfected cells were used as control.  
. Different con tal RNA was extracted after 24 h 
n; mRNA levels were determined by RT-PCR analysis. Mock infected cells and active infected cells 
(m.o.i. 5) were used as control. 
 
d to be substrates of CPAF 
can transmit death signals to 
ochondria by inhibiting the anti-apoptotic Bcl-2 subfamily members and/or activating the 
pr ultidomain Bcl-2 fam  memb  such ax and Bak. Degradation of 
these pro ay act as one mechanism to pr ydial infected cells against 
death stimuli like staurosporine.  
A
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B centrations of IFN-γ were used to induce persistence. To
infectio
The proapoptotic BH-3 proteins (Bad, Puma, Bim) are confirme
during active infection (Pirbhai, M., 2006). BH-3 only proteins 
mit
o-apoptotic m ily ers as B
teins m otect the chlam
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estern blot assays were performed to investigate if the proteins levels of BH-3 are still 
sponded to the apoptotic inhibition in persistently infected cells, as displayed in Figure 
. 23, Bim, Bad and Puma were highly decreased after 48 h active Chlamydia infection. 
uring persistent infection this degradation was protected, however slight reduction of BH-3 
ad 
eins (Bad, Bim and Puma) during persistent Chlamydia infection. 
ifferent concentrations of IFN-γ were used to induce persistence. Whole cell extracts were prepared after 48 h 
post infection and analyzed by immunoblotting.Mock infected cells and active infected cells (m.o.i. 5) were 
us
 
o further confir  persistent infection, 
free degradation assays were performed as previously described. The NE from 
ninfected cells consisting of PARP-1 and HMGB-1 were used as the source of substrates, 
CE from ly infected cells were used to 
ompare the differential activity of CPAF. As expected, the CE from actively infected cells 
displayed obvious proteolytic activity with the strong cleavage and degradation of both 





proteins was still exhibited.  
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Fig. 3. 23 Degradation of BH-3 Prot
D
ed as control.  
T m that there are still proteolytic activities existing in
cell 
u
the  uninfected, actively infected and persistent
c
rikingly, the CE from persistently infected cells showed the slight c
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ARP-1 proteins and no degradation of HMGB-1 proteins, compared to the intact proteins in 
E of persistent cells (Fig. 3. 24), suggesting that CPAF existed only in the cytosol of 
ersistently infected cells, but not translocated to the nuclear.  
NE Mock Mock Active Mock Persistent Mock 
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Fig. 3. 24 Cell free degradation assay of the PARP-1 and HMGB-1 proteins. 
Cytosolic and nuclear fractions were prepared from cell samples collected at 48 h after infection and analyzed 
by immunoblotting. Cytosolic fractions from mock-, active- and persistent-infected cells were tested in a cell 
free cleavage assay using nuclear fractions from mock-infected cells as the PARP-1 and HMGB-1 containing 
substrates. NE, nuclear extract; CE, cytosolic extract  
 
 25 kDa 
 17 kDa 
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4.1 Chlamydia regulated host cell death pathways 
cellular bi-phasic developmental cycle. Many 
previous studies have confirmed that Chlamydia can modulate host cell death pathways to 
complete its own development, start a new replication cycle, and defense host cells against 
death stimuli.  
It has been described that Chlamydia either induces or inhibits host-cell death during 
infection (Fischer, S. F., 2003; Byrne, G. I., 2004). On the one hand, to complete its special 
intracellular developmental cycle, Chlamydia effectively protect host cells against a broad 
spectrum of apoptotic stimuli during infection, on the other hand, induction of cell death in 
the late stage of developmental cycle allows propagation of chlamydia. 
Initially, the apparently contradictory activities of chlamydial infection were viewed as 
controversial (Fields, K. A., 2002). These conflicting interpretations may be due to 
opposing activities (pro- and anti-apoptotic) being expressed at different levels at different 
times of infectious cycle. It is reported that cell death induction mostly happened in the 
latest stage of infection, whereas the inhibition of apoptosis existed in earlier stage. Other 
discrepancies would be due to the use of different Chlamydia strains, infectious doses or 
host-cell types. For instance, primary fibroblasts are more sensitive to apoptosis during 
chlamydia infection than HeLa cells (Miyairi, I., 2006). 
Our study gives the clear evidence that C. trachomatis serovar D infection induces a type 
of cell death in epithelial HeLa cells. By flow cytometry, most of the infected cells were 
stained by Annexin-V and PI double positive staining, suggesting this cell death is 
characterized by loss of plasma membrane integrity and phosphatidylserine exposure. This 
death induction happened not in the beginning of the developmental cycle (10 h p.i.) but in 
the middle and late stage (24 and 48 h p.i.), thus it may contribute to the propagation of 
Chlamydia and act as a mechanism of disease pathogenesis by stimulating inflammatory 
response.  
In classical apoptotic pathways, the activation of effector caspase-3 plays an important role 
on the death events for apoptosis. However, this apoptotic factor is not activated during 
4 Discussion 
 
The relationship between Chlamydia and its host is distinct in that the pathogen can exploit 
host cell resources throughout their intra
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. Besides, many other apoptotic factors do not correspond to the 
ple, the pro-apoptotic factors cytochrome c and 
AIF, which are released from mitochondria and act as death signals in response to 
ion. These results confirmd 
that cell death induced by chlamydial infection is independent of the classical apoptotic 
 or by delivering the intracellular pathogens to 
competent professional phagocytes, thus Chlamydia anti-apoptotoc activity may be 
other evidence that 
olecular structure of this protein 
00).  
chlamydial infection
chlamydial induced cell death. For exam
apoptosis, still remained in mitochondria after chlamydial infect
pathway.  
Host response can facilitate the killing of intracellular bacteria localized in cytoplasmic 
vacuoles by either provoking an inflammatory response (Molloy, A., 1994; 
Laochumroonvorapong, P., 1996)
involved to suppress the host response to the initial intracellular invasion and complete its 
developmental cycle. As expected, when the host cells are treated by apoptotic stimuli like 
staurosporine, the hallmarks of apoptosis like the nuclear fragmentation and activated 
caspase-3 are efficiently inhibited by Chlamydia infection, which is also consistent with 
the reports from other groups (Fan, T., 1998). This result also gave an
C. trachomatis induced cell death is independent of the caspase-3 in the classical apoptotic 
pathway.  
4.2 PARP-1 cleavage during C. trachomatis infection 
Poly (ADP-ribose) polymerase-1 (PARP-1, 113 kDa), a DNA-repair and protein-
modifying enzyme, is an abundant nuclear protein that participates in the regulation of 
DNA repair and genomic integrity maintenance. The m
comprises three main distinct regions: an N-terminal DNA-binding domain (DBD), a 
central auto-modification domain, and a C-terminal catalytic domain (D'Amours, D., 
1999). (Fig. 4. 1) 
In response to mutagenic stress signals, PARP-1 activity is stimulated more than 500-fold 
upon binding to DNA strand-breaks. Subsequentially, it catalyzes and transfers poly (ADP-
ribose) polymers onto itself and other nuclear proteins and presumably facilitate DNA 
repair, thereby contributing to the maintenance of genomic integrity (Lindahl, T., 1995; 
Shall, S., 20
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Fig. 4. 1 Schematic representation of the structure of poly (ADP-ribose) polymerase (PARP-1) 
 
During apoptosis, activated caspase-3 cleaves the 113 kDa form of PARP-1 at the DEVD 
site to generate two fragments of 89 and 24 kDa (Kaufmann, S. H., 1993; Lazebenik, Y. 
 
sentially inactivates the 
enzyme by separation of the two zinc-finger DNA-binding motifs from the 
ity is a significant contributor to necrotic cell death (Gobeil, 
Sims, J. L., 1983). In this case, PARP-1 activity has a cytotoxic role 
within the cells, and the inhibition of PARP-1 with small molecules chemical inhibitor has 
A., 1994), which become a hallmark of apoptosis. This cleavage es
automodification and catalytic domains and subsequently destroying its ability to respond 
to DNA strand breaks. Thus, inactivation of PARP-1 obviously prevents the depletion of 
NAD+ and ATP during late apoptosis (Boulares, A. H., 1998).  
However, excessive DNA damage generates large branched-chained poly (ADP-ribose) 
polymers, which leads to the activation of a unique cell-death program. It is also apparent 
that an altered PARP-1 activ
S., 2001). PARP-1 fragmentation also occurred in necrotic cell death. During necrosis, the 
activity of the PARP-1 is upregulated, resulting in extensive poly (ADP-ribosylation) of 
nuclear proteins, using NAD+ as its substrate, which in turn leads to the depletion of NAD+ 
and ATP energy stores inside the cells, ultimately leading to necrosis. (Zhang, J., 2000; 
Szabo, C., 1998; 
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been shown to increase the sensitivity of cells to cytotoxic agents in a wide variety of in 
vivo (Griffin, R. J., 1996; Cosi, C., 2004).  
Actually, because of the rapid activation of PARP-1, the intensity of PARP-1 activation 
might be a key factor that prevents the depletion of the cellular energy and regulate 
whether cells die or survive. Now, PARP-1 is used to distinguish apoptosis and necrosis 
depending on its different cleavage and activity. Strikingly, after C. trachomatis D 
infection, without the activation of caspase-3, PARP-1 is found to be cleaved into a multi-
pattern form, which shows the necrotic cleavage feature (72, 55 and 42 kDa) rather than 
the apoptotic cleavage (89 and 24 kDa). However, the PARP-1 activity is declined after 
cleavage, indicating that capacity to regulate DNA repair mechanisms is impaired, and the 
subsequent depletion of ATP is also inhibited during the DNA damage. Thus, the loss of 
PARP-1 activity may silent the host reaction to DNA damage stress.  
It is already known that the over activation of PARP-1 can induce necrosis and plays a role 
 a type of caspase-independent programmed cell death. Poly (ADP-ribose) polymer 
signal hich, 
in turn, causes nuclear condensation (Wang, Y., 2009). From this point of view, the 
hen chlamydial inclusions 
spectrometry, CPAF was identified as the Chlamydia-specific protease cleaving PARP-1. 
in
ing mediates the translocation of AIF from the mitochondriae into the nucleus w
degradation of PARP-1 by Chlamydia at middle stage of the developmental cycle may 
contribute to strategies that prevent rapid cell death following infection. Because PARP-1 
is also involved in the maintenance of cellular homeostasis and regulation of DNA repair; 
the silencing of PARP-1 by siRNA transfection in host cells results in the induction of cell 
death which is similar like that induced by chlamydial infection, suggesting that PARP-1 
cleavage contributes to chlamydia induced cell death at later stage. 
Concerning that PARP-1 cleavage starts at 16 h post infection w
have been developed and Chlamydia have high metabolic activity. PARP-1 cleavage and 
the loss of its activity might avoid the energy consumption of host cells and promote the 
replication of the pathogen.  
4.3 CPAF causes the PARP-1 cleavage  
The time course of PARP-1 cleavage is consistent with the time course of the CPAF 
expression of C. trachomatis. After separation of this proteolytic factor from the cytosolic 
extraction of infected cells, analyzed by 2D-gel analysis combined with mass 
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hen whole cell lysates were treated, PARP-1 
a by Chlamydia and 
te chlamydial vacuole 
., 2004).  
Our results identified PARP-1 as a new substrate of CPAF. This is also consistent with 
owed that the transfection of cells with 
CPAF resulted in the fragmentation of several host cell proteins including PARP-1 and 
Because the CPAF inhibitor lactacystin could prevent PARP-1 degradation when being 
added to the cells after infection but not w
cleavage occurs within the infected cell and was not an artificial finding resulting from 
CPAF-mediated effects during sample preparation.  
However, treatment of infected HeLa cells with the CPAF inhibitor lactacystin had no 
significant effect on the progeny of chlamydial elementary bodies, which means the CPAF, 
as a ubiquitous enzyme secreted from chlamydial inclusion to the host cell cytosol, 
participating in degradation of many host proteins and acting as a very important virulence 
factor, seems not to be directly related to the developmental cycle of Chlamydia.  
The Chlamydia genome encodes 16 proteases. For example, the CT441, a putative serine 
protease, could cleave p65/RelA of NF-κB pathway (Lad, S. P., 2007). Zhong et al. have 
firstly identified CPAF, which is synthesized as a proenzyme 70 kD
has to be processed into intramolecular dimers 35-kDa C-terminal and a 29-kD N-terminal 
subunit to acquire proteolytic activity (Zhong, G., 2001; Dong, F., 2004). This protease is 
secreted from the inclusion into the host cells cytosol, proteolytically activated and 
degrades several host proteins.  
Until now, CPAF was confirmed to be responsible for the degradation of host transcription 
factors required for major histochompatibility complex (MHC) antigen expression such as 
RFX-5 and USF-1 (Zhong, G., 2001), which may allow Chlamydia to escape efficient 
detection by the immune system. CPAF further disables adaptive immune responses by 
degrading factors required for lipid antigen presentation (CD1d) (Kawana, K., 2007). It can 
also cleave cytokeratin 8 (Dong, F., 2004), which may facilita
expansion and intra-vacuole growth. At middle stage of the infectious cycle, CPAF 
degrades BH-3 only domain pro-apoptotic proteins, ensuring a complete shut down of the 
infected cells ability to undergo apoptosis in response to intrinsic and extrinsic stimuli 
(Pirbhai, M., 2006; Greene, W
another report form Paschen et al. (2008), which sh
induced morphological changes and cell death, suggesting that CPAF acts as a virulence 
factor for chlamydial pathogenicity and might be involved in causing protracted infections.  
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ocation of CPAF. Additionally, C. 
P., 2002).  
unctions: the intracellular form facilitates DNA 
would benefit Chlamydia intracellular parasite.  
CPAF has been described to be mainly located in the cytoplasmic compartment of the host 
cell. At present it is unclear how CPAF is translocated into the nucleus to degrade nuclear 
proteins. Concerning on the activated caspase-3 translocated to nucleus during apoptosis, 
the same channel may be also used for transl
trachomatis-infected epithelial cells typically undergo mitosis without cell division. It may 
be supposed that CPAF also get contact to nucleus-associated proteins during these mitotic 
events.  
4.4 HMGB-1 degradation in the late stage of infection 
HMGB-1 (high mobility group box 1) chromosomal protein associates loosely with 
chromatin of both interphase and mitotic cells, where it regulates gene transcription. 
HMGB-1 has been shown to interact with and increase the apparent binding affinity of 
several transcription factors. In addition, HMGB-1 is also leaked rapidly into the 
extracellular medium when plasma membrane integrity is lost in permeabilized or necrotic 
cells (Müller, S., 2001; Scaffidi, 
Jungas et al. (2004) have suggested that for both HeLa cells and primary fibroblasts, 
HMGB-1 was decreased following infection with C. trahcomatis, based on the observation 
that HMGB-1 is lost in the cells. Interestingly, in our experiments, at a late stage of the C. 
trachomatis infection, both extracellular and intracellular HMGB-1 proteins were highly 
decreased compared to mock infected cells. Together with the further cell free degradation 
assay, it has been demonstrated that the disappearance of HMGB-1 results from certain 
degradation by the proteolytic factor in infected cell. The fractions from column 
chromatography that caused PARP-1 cleavage were also responsible for the HMGB-1 
degradation, demonstrating the CPAF was related to the HMGB-1 degradation.  
HMGB-1 evolves several biological f
binding, stabilizes nucleosome formation, and acts as a transcriptional regulator (Calogero, 
S., 1999). During C. trachomatis infection, the degradation of HMGB-1 was only 
happened in the latest stage (48 h post infection), but not in the earlier stage (24 h post 
infection), when the CPAF has already proteolytic activity to cleave PARP-1, suggesting 
that keeping the regulatory function of HMGB-1 in gene transcription during the infection 
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stimulates monocytes to secrete a subset of pro-inflammatory cytokines, including 
TNF-α and IL-1 (Andersson, U., 2000). Thus, by degrading HMGB-1 in the latest stage, 
ay act as a virulence 
factor that prevents extensive inflammation, thereby contributing to immune evasion 
nd morphologically altered form so called 
ryptophan 
On the other hand, extracellular HMGB-1 released from necrotic cells has been implicated 
to act as a potent inflammatory mediator (Landsman, D., 1993; Giese, K., 1992; Wang, H., 
1999). The activation of PARP-1 regulates the translocation of HMGB-1 from the nucleus 
to the cytosol, which serves to establish the ability of cells to release it upon subsequent 
necrosis (Ditsworth, D., 2007). Once released, HMGB-1 is able to activate several other 
cells involved in the immune response or inflammatory reactions, and act as a cytokine by 
itself. It 
when large amounts of infected cells undergo cell death, CPAF m
strategies of the Chlamydia.  
4.5 Chlamydial persistent infection  
In recent years, it has become apparent that Chlamydiae can switch in cell culture and in 
the host organism to a metabolically a
persistence (Hogan, R. J., 2004). Chlamydial persistence is known as a state of infection 
during which the pathogen remains viable but non-cultivable, while the host immune 
system is incapable of eliminating it. It is frequently involved in chronic diseases 
associated with inflammatory processes, thus becomes an important issue for Chlamydia 
research.  
Although the host response occurs to eradicate infection, it may also contribute to initiation 
of a persistent chlamydia infection. In vivo, the immune response against Chlamydia 
mostly depends on the inflammatory cytokine gamma interferon (IFN-γ). IFN-γ suppressed 
Chlamydia mainly through the induction of IDO, subsequently leading to t
starvation; which is an important amino acid Chlamydia obtained from host cell pool. 
In this study, a persistent form was established by C. trachomaits D infection under the 
IFN-γ stress. It is known that the different chlamydial strains exhibit differential sensitivity 
on IFN-γ. C. trachomatis D is resistant to IFN-γ due to its own tryptophan synthase and 
utilization of indole as a substrate for tryptophan synthesis. However, pre-treatment host 
cells with 5 ng/ mL IFN-γ resulted in the induction of IDO, which efficiently eliminates 
this resistance and induce the persistence.  
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 resists on apoptotic stimuli  
een demonstrated to both induce cell death 
and inhibit apoptotic stimuli to ensure the complete of developmental cycle and start new 
 infected cells to ensure indefinite survival of the bacterial while expressing 
ydial 
Morphologically, the persistent Chlamydia is characterized by reduced inclusion size and 
enlarged, pleomorphic RBs which are inhibited in binary fission and their differentiation 
to EBs. On the molecular level, compared with active infection, persistent bacteria exhibit 
altered protein expression, metabolism activity and often resistance to antibiotic therapy. 
For instance, immunoblot results showed that the MOMP-to-cHsp60 ratio was 
significantly reduced, which served as a marker of persistence. The reduced levels of 
MOMP, as an immunoprotective antigen, could enable chlamydia to avoid the 
development of protective immunity. In contrast, the steady level of cHSP60 would 
promote immuno-pathology through delayed-type hypersensitivity (Betty, W. L., 1993).  
4.6 Persistent infection
The active Chlamydia infection has already b
infection. It is known that persistent chlamydia can persist for as long as 5 years in the 
genital tract in vivo (Dean, D., 2000).  
Thus the protection of the persistently infected cells against death stimuli and the host 
immune system may benefit Chlamydia to establish long-term infection. The cHsp60, an 
immunopathological antigen to elicit the hypersensitivity reactions of hosts, is maintained 
during persistence also suggesting an apoptotic inhibition mechanism may exist in 
persistently
their most inflammatory antigen. 
Herein, we confirmed that although IFN-γ itself induced the apoptosis of eukaryotic cells 
in the absence of infection, persistent C. trachomatis infection under IFN-γ stress still 
exhibited the inhibition of apoptosis induced by staurosporine. Anti-apoptotic activity is 
prolonged during chlamydial persistence, which strengthens the hypothesis that chlam
metabolism maintains host cell integrity and contributes to intracellular survival.  
The ability to establish a persistent infection is an important step in the pathogenesis of 
scarring disease seen in both trachoma and chlamydial sexually transmitted diseases. Thus, 
resistance to cell death by Chlamydia persistent infection may establish a continuous 
antigenic pool that stimulates ongoing inflammation and subsequent fibrosis.  
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During active 
pattern form and induces a caspase-3 indepe
inf
immune system
nucleus, giving the explanation that persistent Chlamydia might ensure the integrity of host 
n factors.  
. Heuer (2003) further indicated that CPAF 
transclocation was separated from its production. The translocation mechanism was fully 
um in 24 h post infection, when Chlamydia had the most 
activity. However, during the IFN-γ induced persistence, the expression of CPAF was 
locate in the cytosol of host cells and transmit death signal to mitochondria by inhibiting 
d cells. This 
4.7 Persistence regulates death pathways by different CPAF expression 
profile 
It has long been known that host factors are important in disease progression; we compared 
the different protein profiles during the active and persistent infection.  
Chlamydia infection, CPAF cleaves nuclear proteins PARP-1 to a multi-
ndent cell death. It also degrades the 
lammation factor HMGB-1 in the latest stage of developmental cycle to avoid the host 
. However, during persistence, both proteins were detected to be intact in 
cells for a long-term survival without stimulating the inflammatio
Cell free degradation demonstrated that the cytosolic extraction from persistently infected 
cells slightly degrades the nuclear proteins PARP-1 and HMGB-1. It has already been 
reported that little or no differential expression of CPAF between persistent and active 
infections (Hogan, R. J., 2004; Heuer, D., 2003)
activated during active infection; however, during persistent infection induced by IFN-γ, it 
is fully or partially inhibited.  
In this study, the expression of CPAF was also compared between active and persistent 
infection by RT-PCR. During active infection, CPAF transcription began at 12 h post 
infection and arrived to the maxim
efficiently decreased but not totally blocked; suggesting a small amount of CPAF exists in 
the infected cells to play a certain role in interaction with host cell signal pathway.  
CPAF is also known to interfere with the apoptotic pathway by degrading the pro-
apoptotic BH-3 only proteins during active infection (Pirbhai, M., 2006). BH-3 proteins 
the anti-apoptotic Bcl-2 subfamily members or activating the pro-apoptotic Bcl-2 family 
members such as Bax and Bak (Willis, S. N., 2005; Bouillet, P., 2002). Our results 
illustrated that in persistently infected cells, BH-3 proteins were still partially degraded 
compare to the mock infected cells, but increased compared to actively infecte
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The different CPAF expression profiles in active and persistent infection may give us some 
nce.  
also confirms that during persistent infection of Chlamydia, the CPAF is slightly expressed, 
but the translocation of CPAF to the host nucleus is inhibited.  
explanations of how persistent Chlamydia can protect the host cells against some apoptotic 
stimuli, spontaneously keep the host cells integrity for long-term persiste
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haracteristic 
of a non-apoptotis caspase-independent cell death.  
Chlamydia-secreted protease CPAF interferes with many host functions by degrading a 
series of host proteins. Herein, two nuclear proteins, PARP-1 and HMGB-1, are identified 
as new substrates of CPAF. Upon a replicative chlamydial infection, PARP-1, a DNA 
repair enzyme, is cleaved by CPAF into multi-fragment during the middle and late stages 
of infection. This PARP-1 cleaveage is related to the loss of its DNA repair activity, which 
is involved in the host cell death induction by Chlamydia. In the late stage of infection, 
CPAF also degrades the HMGB-1 to prevent the release of this inflammatory factor to the 
extracellular matrix (Fig. 5. 1 left).  
Under IFN-γ stress, C. trachomatis undergoes a persistent infection form, which shows 
low cultivability and long-term relationship with the host cells. During persistent 
chlamydial infection, CPAF expression is decreased. It ceases to translocate to host 
nucleus, thus the nuclear proteins (PARP-1 and HMGB-1) keep intact, which may ensure 
the long-term homeostasis of host cells without stimulating host immune system. However, 
the pro-apoptotic proteins BH-3 are partially decreased to protect the persistent cells 
against the remained death stress in vivo. The balance between the cell death induction and 
protection against death stimuli may ensure the persistent Chlamydia long-term 







C. trachomatis exhibits the activities of both inducing host cell death and protecting the 
infected cells against apoptotic stimuli. In this study, the Chlamydia-induced cell death was 
investigated. Upon infection with C. trachomatis D the host cell displays the c
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ig. 5. 1 Chlamydia interfere with host cells death pathways during different condition 
 
 





PARP-1 is cleaved with 
activity loss ---- cell death 
induction 
 
HMGB-1 is degraded ----
PARP-1 keeps intact----long-
term persistent in host cells 
 
HMGB1 keeps intact----no 
avoid immune system 
 






BH-3 BH-3 pro-apoptotic 
proteins are degraded ----
anti-apoptotic activity 
BH-3 pro-apoptotic proteins 
are partially degraded ---- 
anti-apoptotic activity 
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